| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABL1 ABI3 MAP1B MYO5A KIF26A MARK1 EML6 WIPF3 PACSIN3 MAP3K1 KIF9 DLC1 BRCA2 MTUS1 SVIL NAV3 LMOD1 KIF3C SGIP1 ANK3 NRCAM COBLL1 NCKIPSD VASH1 NUMA1 TOGARAM2 MYO18A TPPP DNM1L KIF3A MAP1S SIPA1L1 MARK2 PALLD MYBPC3 | 1.06e-07 | 1099 | 238 | 35 | GO:0008092 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | ZMYND8 CHD1 KMT2E GLYR1 PHIP NCAPD3 ANK3 MTF2 NPLOC4 ZZZ3 SMARCA4 TP53BP1 | 7.16e-06 | 206 | 238 | 12 | GO:0140030 |
| GeneOntologyMolecularFunction | methylated histone binding | 8.63e-06 | 86 | 238 | 8 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.02e-05 | 88 | 238 | 8 | GO:0140034 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MCM8 MYO5A VWA8 KIF26A CHD1 ATP8B1 HELB BLM KIF9 DDX46 NAV3 NAV2 KIF3C DYNC1H1 SMARCAL1 MYO18A SAE1 ATP8B2 KIF3A SMARCA4 DYNC1LI1 | 1.58e-05 | 614 | 238 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule binding | MAP1B KIF26A EML6 KIF9 MTUS1 NAV3 KIF3C SGIP1 NUMA1 TOGARAM2 TPPP DNM1L KIF3A MAP1S | 2.12e-05 | 308 | 238 | 14 | GO:0008017 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MCM8 VWA8 KIF26A CHD1 ATP8B1 HELB BLM KIF9 DDX46 NAV3 NAV2 KIF3C DYNC1H1 MYO18A ATP8B2 KIF3A SMARCA4 | 2.36e-05 | 441 | 238 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | tubulin binding | MAP1B KIF26A EML6 WIPF3 KIF9 BRCA2 MTUS1 NAV3 KIF3C SGIP1 NUMA1 TOGARAM2 TPPP DNM1L KIF3A MAP1S | 5.93e-05 | 428 | 238 | 16 | GO:0015631 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.59e-05 | 118 | 238 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.44e-04 | 127 | 238 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.87e-04 | 70 | 238 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | MCM8 CHD1 HELB BLM NAV2 NIPBL SGIP1 SMARCAL1 MYO18A MAP1S SMARCA4 | 3.23e-04 | 262 | 238 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | histone binding | ZMYND8 CHD1 KMT2E GLYR1 MCM3AP PHIP NCAPD3 MTF2 ZZZ3 SMARCA4 TP53BP1 | 3.55e-04 | 265 | 238 | 11 | GO:0042393 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MCM8 VWA8 KIF26A LSG1 CHD1 ATP8B1 HELB BLM KIF9 DDX46 NAV3 NAV2 KIF3C DYNC1H1 MYO18A TPPP DNM1L ARHGAP35 ATP8B2 KIF3A SMARCA4 | 4.13e-04 | 775 | 238 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 4.23e-04 | 30 | 238 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.81e-04 | 31 | 238 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | helicase activity | 6.29e-04 | 158 | 238 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 6.84e-04 | 15 | 238 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | magnesium ion binding | ABL1 MARK1 SRPK2 ATP8B1 EYA2 OXSR1 CDC42BPA TPPP ATP8B2 MARK2 | 7.94e-04 | 247 | 238 | 10 | GO:0000287 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MCM8 VWA8 KIF26A LSG1 CHD1 ATP8B1 HELB BLM KIF9 DDX46 NAV3 NAV2 KIF3C DYNC1H1 MYO18A TPPP DNM1L ARHGAP35 ATP8B2 KIF3A SMARCA4 | 1.14e-03 | 839 | 238 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MCM8 VWA8 KIF26A LSG1 CHD1 ATP8B1 HELB BLM KIF9 DDX46 NAV3 NAV2 KIF3C DYNC1H1 MYO18A TPPP DNM1L ARHGAP35 ATP8B2 KIF3A SMARCA4 | 1.15e-03 | 840 | 238 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MCM8 VWA8 KIF26A LSG1 CHD1 ATP8B1 HELB BLM KIF9 DDX46 NAV3 NAV2 KIF3C DYNC1H1 MYO18A TPPP DNM1L ARHGAP35 ATP8B2 KIF3A SMARCA4 | 1.15e-03 | 840 | 238 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 1.41e-03 | 41 | 238 | 4 | GO:0140463 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.66e-03 | 143 | 238 | 7 | GO:0017124 | |
| GeneOntologyMolecularFunction | actin binding | ABL1 ABI3 MAP1B MYO5A WIPF3 SVIL LMOD1 COBLL1 VASH1 MYO18A MAP1S SIPA1L1 PALLD MYBPC3 | 1.91e-03 | 479 | 238 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 2.06e-03 | 6 | 238 | 2 | GO:0140345 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ABL1 MAP1B INCENP MYO5A KIF26A MARK1 ASH1L QRICH2 FSIP2 KIF9 BRCA2 NAV3 KIF3C ODAD3 AP3D1 DYNC1H1 DYNC1LI2 CDC42BPA ANK3 NUMA1 TOGARAM2 TPPP SRGAP2 CEP192 KIF3A C2CD3 MAP1S RP1L1 DYNC1LI1 MARK2 CFAP44 SON | 6.09e-07 | 1058 | 238 | 32 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ABL1 MAP1B INCENP MARK1 FSIP2 BRCA2 NAV3 ODAD3 DYNC1H1 DYNC1LI2 CDC42BPA ANK3 NUMA1 TOGARAM2 TPPP SRGAP2 CEP192 KIF3A C2CD3 MAP1S RP1L1 DYNC1LI1 MARK2 CFAP44 SON | 1.02e-06 | 720 | 238 | 25 | GO:0000226 |
| GeneOntologyBiologicalProcess | chromatin organization | BRPF3 H1-7 ZMYND8 ASH1L SRPK2 HMGN1 CHD1 EYA2 KMT2E TRIP12 KMT2C TLK1 SAFB BRCA2 GLYR1 MCM3AP MKI67 KDM2B NIPBL RBM15 MTF2 SMARCAL1 NIBAN2 ZZZ3 MDC1 SMARCA4 BICRAL TP53BP1 | 1.75e-06 | 896 | 238 | 28 | GO:0006325 |
| GeneOntologyBiologicalProcess | neuron projection development | ABL1 ABI3 MAP1B UBE4B MYCBP2 KIF26A MARK1 ZMYND8 GPRIN1 FBXO38 NKX2-8 ANAPC2 KIF3C ACAP3 FAT4 NYAP2 ANK3 NRCAM FAT3 NCKIPSD DNM1L FRYL POU4F3 SRGAP2 NIBAN2 ARHGAP35 TFAP4 KIF3A MAP1S EGR2 SIPA1L1 LRP1 ROBO2 MARK2 PALLD | 1.93e-06 | 1285 | 238 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ABL1 ABI3 MAP1B MYCBP2 SIPA1L3 MAP3K1 NKX2-8 FAT1 DLC1 ANAPC2 FGD5 PHIP BRWD1 NYAP2 ANK3 NRCAM FAT3 DNM1L FRYL POU4F3 SRGAP2 NIBAN2 ARHGAP35 KIF3A MAP1S EGR2 SIPA1L1 LRP1 SMARCA4 ROBO2 MARK2 CFAP44 PALLD | 2.88e-06 | 1194 | 238 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ABL1 ABI3 MAP1B INCENP MYO5A MYCBP2 ZMYND8 MAP3K1 KIF9 DLC1 SVIL ANAPC2 MKI67 NAV3 LMOD1 ODAD3 PHIP DYNC1H1 NCAPD3 EXOSC10 TBC1D30 NUMA1 TOGARAM2 TPPP DNM1L CEP192 ARHGAP35 ARHGEF15 MAP1S SIPA1L1 LRP1 SMARCA4 DYNC1LI1 MARK2 TNKS2 | 5.07e-06 | 1342 | 238 | 35 | GO:0033043 |
| GeneOntologyBiologicalProcess | neuron development | ABL1 ABI3 MAP1B UBE4B MYCBP2 KIF26A MARK1 ZMYND8 ATP8B1 GPRIN1 FBXO38 NKX2-8 ANAPC2 KIF3C ACAP3 FAT4 NYAP2 ANK3 NRCAM FAT3 NCKIPSD DNM1L FRYL POU4F3 SRGAP2 NIBAN2 ARHGAP35 TFAP4 KIF3A MAP1S EGR2 SIPA1L1 RP1L1 LRP1 ROBO2 MARK2 PALLD | 5.31e-06 | 1463 | 238 | 37 | GO:0048666 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BRPF3 H1-7 ZMYND8 ASH1L SRPK2 HMGN1 CHD1 EYA2 KMT2E TRIP12 KMT2C TLK1 SAFB BRCA2 GLYR1 MCM3AP MKI67 KDM2B NIPBL RBM15 MTF2 SMARCAL1 NIBAN2 ZZZ3 MDC1 SMARCA4 BICRAL TP53BP1 | 1.35e-05 | 999 | 238 | 28 | GO:0071824 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | ABL1 MAP1B SIPA1L3 FAT1 AMOTL1 ANK3 NUMA1 MYO18A ARHGAP35 KIF3A MARK2 EXOC4 | 4.69e-05 | 257 | 238 | 12 | GO:0007163 |
| GeneOntologyBiologicalProcess | viral transcription | 5.43e-05 | 58 | 238 | 6 | GO:0019083 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | INCENP PPP2R2D KMT2E CDK14 BLM BRCA2 ANAPC2 MKI67 NIPBL PHIP DYNC1H1 TICRR NCAPD3 ANK3 NUMA1 CEP192 TFAP4 LARP7 MAP1S MDC1 SMARCA4 DYNC1LI1 SON EXOC4 | 5.57e-05 | 854 | 238 | 24 | GO:1903047 |
| GeneOntologyBiologicalProcess | microtubule-based movement | MAP1B MYO5A KIF26A ASH1L QRICH2 FSIP2 KIF9 KIF3C ODAD3 AP3D1 DYNC1H1 DYNC1LI2 ANK3 KIF3A MAP1S DYNC1LI1 CFAP44 | 6.36e-05 | 493 | 238 | 17 | GO:0007018 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ABL1 ABI3 MAP1B MYCBP2 KIF26A MARK1 FBXO38 ANAPC2 KIF3C ACAP3 NRCAM FAT3 NCKIPSD DNM1L ARHGAP35 SIPA1L1 LRP1 ROBO2 MARK2 | 9.56e-05 | 612 | 238 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ABL1 ABI3 MAP1B MYCBP2 KIF26A MARK1 ZMYND8 ATP8B1 FBXO38 ANAPC2 KIF3C ODAD3 ACAP3 NRCAM TBC1D30 FAT3 NCKIPSD DNM1L ARHGAP35 SIPA1L1 LRP1 ROBO2 MARK2 | 1.31e-04 | 846 | 238 | 23 | GO:0120035 |
| GeneOntologyBiologicalProcess | transitional one stage B cell differentiation | 1.33e-04 | 2 | 238 | 2 | GO:0002333 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | ABL1 MAP1B KIF9 NAV3 DYNC1H1 NUMA1 TPPP CEP192 KIF3A MAP1S DYNC1LI1 MARK2 | 1.63e-04 | 293 | 238 | 12 | GO:0032886 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | ABL1 ABI3 MAP1B MYCBP2 MARK1 ZMYND8 ANAPC2 NRCAM DNM1L SRGAP2 ARHGEF15 SIPA1L1 ROBO2 MARK2 | 1.73e-04 | 387 | 238 | 14 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ABL1 ABI3 MAP1B MYCBP2 KIF26A MARK1 ZMYND8 ATP8B1 FBXO38 ANAPC2 KIF3C ODAD3 ACAP3 NRCAM TBC1D30 FAT3 NCKIPSD DNM1L ARHGAP35 SIPA1L1 LRP1 ROBO2 MARK2 | 1.75e-04 | 863 | 238 | 23 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | ABL1 ABI3 MAP1B MYCBP2 MARK1 ZMYND8 ANAPC2 NRCAM DNM1L SRGAP2 ARHGEF15 SIPA1L1 ROBO2 MARK2 | 2.14e-04 | 395 | 238 | 14 | GO:0050803 |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 2.15e-04 | 139 | 238 | 8 | GO:0051983 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 2.22e-04 | 177 | 238 | 9 | GO:0030010 | |
| GeneOntologyBiologicalProcess | neuron migration | 2.32e-04 | 218 | 238 | 10 | GO:0001764 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.87e-04 | 145 | 238 | 8 | GO:0001578 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | ABL1 INCENP PPP2R2D KMT2E CDK14 BLM BRCA2 ANAPC2 MKI67 NIPBL PHIP DYNC1H1 TICRR NCAPD3 ANK3 NUMA1 CEP192 TFAP4 LARP7 MAP1S MDC1 SMARCA4 DYNC1LI1 SON EXOC4 | 2.99e-04 | 1014 | 238 | 25 | GO:0000278 |
| GeneOntologyBiologicalProcess | central nervous system development | FOXR1 POU6F2 ABL1 MYCBP2 KIF26A CIC DLC1 BRCA2 NAV2 KDM2B NIPBL ODAD3 NPAS2 FAT4 NRCAM TPPP SRGAP2 ARHGAP35 KIF3A NCOR2 C2CD3 MAP1S EGR2 LRP1 SMARCA4 ROBO2 PAX5 EXOC4 | 3.03e-04 | 1197 | 238 | 28 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 3.09e-04 | 185 | 238 | 9 | GO:0099175 | |
| GeneOntologyBiologicalProcess | axonogenesis | ABL1 MAP1B MYCBP2 NKX2-8 ANAPC2 ANK3 NRCAM POU4F3 NIBAN2 ARHGAP35 MAP1S EGR2 SIPA1L1 LRP1 ROBO2 MARK2 PALLD | 3.28e-04 | 566 | 238 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 3.47e-04 | 188 | 238 | 9 | GO:0000724 | |
| GeneOntologyBiologicalProcess | response to X-ray | 3.74e-04 | 30 | 238 | 4 | GO:0010165 | |
| GeneOntologyBiologicalProcess | transitional stage B cell differentiation | 3.95e-04 | 3 | 238 | 2 | GO:0002332 | |
| GeneOntologyBiologicalProcess | chromosome organization | DTD1 ABL1 MCM8 INCENP H1-7 HELB BLM BRCA2 ANAPC2 NAV2 NIPBL NCAPD3 EXOSC10 SMARCAL1 NUMA1 CEP192 SMARCA4 DYNC1LI1 TNKS2 | 4.05e-04 | 686 | 238 | 19 | GO:0051276 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | MAP1B INCENP MAP3K1 DLC1 SVIL NAV3 LMOD1 EXOSC10 TBC1D30 TOGARAM2 DNM1L CEP192 DYNC1LI1 TNKS2 | 4.07e-04 | 421 | 238 | 14 | GO:0010639 |
| GeneOntologyBiologicalProcess | brain development | FOXR1 ABL1 KIF26A CIC DLC1 BRCA2 NAV2 KDM2B NIPBL ODAD3 FAT4 NRCAM SRGAP2 ARHGAP35 KIF3A NCOR2 C2CD3 MAP1S EGR2 SMARCA4 ROBO2 PAX5 | 4.18e-04 | 859 | 238 | 22 | GO:0007420 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ABL1 ABI3 MAP1B MYCBP2 NKX2-8 ANAPC2 NYAP2 ANK3 NRCAM DNM1L POU4F3 SRGAP2 NIBAN2 ARHGAP35 MAP1S EGR2 SIPA1L1 LRP1 ROBO2 MARK2 PALLD | 4.24e-04 | 802 | 238 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | ABL1 MAP1B MYCBP2 MAP3K1 DLC1 SVIL NAV3 LMOD1 DYNC1H1 NUMA1 TOGARAM2 TPPP ARHGAP35 ARHGEF15 MAP1S LRP1 MARK2 | 4.25e-04 | 579 | 238 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | head development | FOXR1 ABL1 KIF26A CIC DLC1 BRCA2 NAV2 KDM2B NIPBL ODAD3 FAT4 NRCAM SRGAP2 ARHGAP35 KIF3A NCOR2 C2CD3 MAP1S EGR2 ANKRD11 SMARCA4 ROBO2 PAX5 | 4.26e-04 | 919 | 238 | 23 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 4.26e-04 | 55 | 238 | 5 | GO:0045910 | |
| GeneOntologyBiologicalProcess | recombinational repair | 4.37e-04 | 194 | 238 | 9 | GO:0000725 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ABL1 ABI3 MAP1B MYCBP2 NKX2-8 ANAPC2 ANK3 NRCAM FAT3 DNM1L POU4F3 NIBAN2 ARHGAP35 MAP1S EGR2 SIPA1L1 LRP1 ROBO2 MARK2 PALLD | 4.47e-04 | 748 | 238 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 4.49e-04 | 155 | 238 | 8 | GO:0051053 | |
| GeneOntologyBiologicalProcess | axon development | ABL1 MAP1B MYCBP2 NKX2-8 ANAPC2 ANK3 NRCAM POU4F3 NIBAN2 ARHGAP35 TFAP4 MAP1S EGR2 SIPA1L1 LRP1 ROBO2 MARK2 PALLD | 4.98e-04 | 642 | 238 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | DNA repair | ABL1 MCM8 ZMYND8 HMGN1 EYA2 TRIP12 HELB BLM BRCA2 NIPBL NPAS2 TICRR EXOSC10 SMARCAL1 PALB2 MDC1 SMARCA4 TP53BP1 | 5.55e-04 | 648 | 238 | 18 | GO:0006281 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ABL1 ABI3 MAP1B MYCBP2 NKX2-8 ANAPC2 NYAP2 ANK3 NRCAM DNM1L POU4F3 SRGAP2 NIBAN2 ARHGAP35 MAP1S EGR2 SIPA1L1 LRP1 ROBO2 MARK2 PALLD | 5.57e-04 | 819 | 238 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell cycle process | INCENP PPP2R2D KMT2E CDK14 BLM TLK1 BRCA2 SVIL ANAPC2 MKI67 NIPBL PHIP DYNC1H1 NPAT TICRR NCAPD3 ANK3 NUMA1 TPPP CEP192 TFAP4 LARP7 KIF3A C2CD3 MAP1S MDC1 SMARCA4 DYNC1LI1 TP53BP1 SON EXOC4 | 5.97e-04 | 1441 | 238 | 31 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABL1 ABI3 MAP1B MYCBP2 MARK1 ZMYND8 ATP8B1 MAP3K1 KIF9 DLC1 SVIL NAV3 LMOD1 ODAD3 DYNC1H1 TBC1D30 NUMA1 ZDHHC5 TPPP SRGAP2 CEP192 ARHGAP35 ARHGEF15 SNCAIP SIPA1L1 LRP1 ROBO2 | 6.15e-04 | 1189 | 238 | 27 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ABL1 ABI3 MAP1B MYCBP2 NKX2-8 ANAPC2 NYAP2 ANK3 NRCAM DNM1L POU4F3 SRGAP2 NIBAN2 ARHGAP35 MAP1S EGR2 SIPA1L1 LRP1 ROBO2 MARK2 PALLD | 6.21e-04 | 826 | 238 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 6.23e-04 | 15 | 238 | 3 | GO:0090235 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | KMT2C BRCA2 UNC79 NIPBL ODAD3 SGIP1 RBBP6 PALB2 ANKRD11 TNKS2 | 6.60e-04 | 249 | 238 | 10 | GO:0035264 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MAP1B INCENP MYO5A KIF26A INPP5D EML6 MAP3K1 KRT80 KIF9 DLC1 MTUS1 SVIL NAV3 LMOD1 KIF3C DYNC1H1 DYNC1LI2 NCKIPSD NUMA1 TOGARAM2 TPPP DNM1L KIF3A MAP1S RP1L1 DYNC1LI1 CLMP MARK2 PALLD CEP170B | 1.37e-07 | 899 | 238 | 30 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear body | ABL1 INCENP LSG1 GON4L SRPK2 ATP8B1 KMT2E TRIP12 HELB BLM DDX46 MKI67 NPAT CASP8AP2 RBM15 SRSF5 RBBP6 POLDIP3 AFF3 PHF7 PALB2 NCOR2 ZNF106 ATOH8 MDC1 SCAF11 SRRM2 TP53BP1 SON | 4.96e-07 | 903 | 238 | 29 | GO:0016604 |
| GeneOntologyCellularComponent | microtubule | MAP1B INCENP KIF26A EML6 KIF9 MTUS1 SVIL NAV3 KIF3C DYNC1H1 DYNC1LI2 NUMA1 TOGARAM2 TPPP DNM1L KIF3A MAP1S RP1L1 DYNC1LI1 CLMP CEP170B | 8.79e-07 | 533 | 238 | 21 | GO:0005874 |
| GeneOntologyCellularComponent | supramolecular fiber | MAP1B INCENP MYO5A KIF26A INPP5D EML6 MAP3K1 KRT80 KIF9 DLC1 MTUS1 SVIL NAV3 LMOD1 KIF3C DYNC1H1 DYNC1LI2 ANK3 NCKIPSD NUMA1 TOGARAM2 MYO18A TPPP DNM1L KIF3A MAP1S RP1L1 DYNC1LI1 CLMP MARK2 PALLD CEP170B MYBPC3 | 1.65e-06 | 1179 | 238 | 33 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MAP1B INCENP MYO5A KIF26A INPP5D EML6 MAP3K1 KRT80 KIF9 DLC1 MTUS1 SVIL NAV3 LMOD1 KIF3C DYNC1H1 DYNC1LI2 ANK3 NCKIPSD NUMA1 TOGARAM2 MYO18A TPPP DNM1L KIF3A MAP1S RP1L1 DYNC1LI1 CLMP MARK2 PALLD CEP170B MYBPC3 | 1.91e-06 | 1187 | 238 | 33 | GO:0099081 |
| GeneOntologyCellularComponent | chromatin | FOXR1 POU6F2 BRPF3 INCENP H1-7 ZMYND8 GON4L SRPK2 HMGN1 CHD1 KMT2E CIC CREBZF NKX2-8 BBX GLYR1 USF1 NIPBL NPAS2 TBX22 NCAPD3 EXOSC10 PHF12 POU4F3 RFX5 TFAP4 NCOR2 ZZZ3 EGR2 ATOH8 ANKRD11 SMARCA4 ZFHX2 NKX1-1 BICRAL PAX5 | 1.27e-05 | 1480 | 238 | 36 | GO:0000785 |
| GeneOntologyCellularComponent | microtubule bundle | 2.84e-05 | 6 | 238 | 3 | GO:0097427 | |
| GeneOntologyCellularComponent | podosome | 9.84e-05 | 41 | 238 | 5 | GO:0002102 | |
| GeneOntologyCellularComponent | microtubule associated complex | MAP1B INCENP KIF9 KIF3C DYNC1H1 DYNC1LI2 KIF3A MAP1S DYNC1LI1 | 9.84e-05 | 161 | 238 | 9 | GO:0005875 |
| GeneOntologyCellularComponent | actin cytoskeleton | ABL1 MYO5A INPP5D SIPA1L3 MAP3K1 KIF9 DLC1 SVIL LMOD1 BIN2 CDC42BPA GFRAL MYO18A ARHGAP35 SH3PXD2A SIPA1L1 MARK2 PALLD | 1.14e-04 | 576 | 238 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | nuclear chromosome | INCENP GON4L CHD1 KMT2E HELB BLM BRCA2 NCAPD3 PHF12 SMARCAL1 SMARCA4 | 1.67e-04 | 254 | 238 | 11 | GO:0000228 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | GON4L KMT2E ZC3H3 CREBZF HELB KMT2C ZMAT5 DDX46 BRCA2 MCM3AP AMOTL1 ANAPC2 KDM2B NIPBL NPAS2 EXOSC10 MTF2 PHF12 SMARCAL1 AFF3 NCKIPSD SAE1 TSEN54 RFX5 LARP7 NCOR2 POLR3B SMARCA4 BICRAL MPHOSPH10 SRRM2 | 2.19e-04 | 1377 | 238 | 31 | GO:0140513 |
| GeneOntologyCellularComponent | microtubule organizing center | EVC KMT2E LUZP1 BRCA2 MTUS1 ODAD3 DYNC1H1 DYNC1LI2 TBC1D30 RBBP6 TEDC2 NUMA1 MYO18A TPPP CEP192 ARHGAP35 KIF3A C2CD3 MAP1S LRP1 DYNC1LI1 TNKS2 EXOC4 | 3.54e-04 | 919 | 238 | 23 | GO:0005815 |
| GeneOntologyCellularComponent | nuclear speck | SRPK2 KMT2E TRIP12 DDX46 RBM15 SRSF5 RBBP6 POLDIP3 PHF7 PALB2 ZNF106 ATOH8 SRRM2 SON | 4.50e-04 | 431 | 238 | 14 | GO:0016607 |
| GeneOntologyCellularComponent | site of polarized growth | 6.74e-04 | 253 | 238 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | anchoring junction | SIPA1L3 ASH1L FAT1 DLC1 PI4KA SVIL AMOTL1 ZFYVE21 TJP2 BIN2 JCAD CDC42BPA COL17A1 GFRAL ANK3 NIBAN2 SH3PXD2A TNFSF13B MDC1 LRP1 CLMP PCDH1 PALLD | 8.08e-04 | 976 | 238 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | dendrite | ABL1 ABI3 MAP1B MYO5A MARK1 ZMYND8 GPR179 SORCS2 KIF3C ANK3 FAT3 NUMA1 ZDHHC5 SRGAP2 ARHGEF15 CNNM1 MAP1S SIPA1L1 LRP1 MARK2 EXOC4 | 8.51e-04 | 858 | 238 | 21 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ABL1 ABI3 MAP1B MYO5A MARK1 ZMYND8 GPR179 SORCS2 KIF3C ANK3 FAT3 NUMA1 ZDHHC5 SRGAP2 ARHGEF15 CNNM1 MAP1S SIPA1L1 LRP1 MARK2 EXOC4 | 8.76e-04 | 860 | 238 | 21 | GO:0097447 |
| GeneOntologyCellularComponent | microtubule end | 8.92e-04 | 38 | 238 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | lateral element | 1.23e-03 | 19 | 238 | 3 | GO:0000800 | |
| GeneOntologyCellularComponent | actin filament | 1.44e-03 | 146 | 238 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | growth cone | 2.05e-03 | 245 | 238 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | DNA repair complex | 2.18e-03 | 23 | 238 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | actomyosin | 2.24e-03 | 117 | 238 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | cytoplasmic dynein complex | 2.47e-03 | 24 | 238 | 3 | GO:0005868 | |
| GeneOntologyCellularComponent | microtubule minus-end | 2.61e-03 | 7 | 238 | 2 | GO:0036449 | |
| HumanPheno | Peritoneal abscess | 1.55e-05 | 11 | 78 | 4 | HP:0100592 | |
| Domain | PHD | 2.29e-06 | 89 | 242 | 9 | SM00249 | |
| Domain | Znf_PHD | 2.76e-06 | 91 | 242 | 9 | IPR001965 | |
| Domain | Znf_FYVE_PHD | BRPF3 ZMYND8 ASH1L KMT2E KMT2C ZFYVE21 KDM2B FGD5 MTF2 PHF12 PHF7 | 3.46e-06 | 147 | 242 | 11 | IPR011011 |
| Domain | ZF_PHD_2 | 3.96e-06 | 95 | 242 | 9 | PS50016 | |
| Domain | ZF_PHD_1 | 4.32e-06 | 96 | 242 | 9 | PS01359 | |
| Domain | Znf_PHD-finger | 8.36e-06 | 79 | 242 | 8 | IPR019787 | |
| Domain | Bromodomain | 8.68e-06 | 38 | 242 | 6 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.37e-05 | 41 | 242 | 6 | PS50014 | |
| Domain | Bromodomain | 1.58e-05 | 42 | 242 | 6 | IPR001487 | |
| Domain | BROMO | 1.58e-05 | 42 | 242 | 6 | SM00297 | |
| Domain | - | 1.58e-05 | 42 | 242 | 6 | 1.20.920.10 | |
| Domain | PHD | 5.27e-05 | 75 | 242 | 7 | PF00628 | |
| Domain | - | BRPF3 UBE4B MYCBP2 ZMYND8 ASH1L KMT2E MAP3K1 BRAP KMT2C ZFYVE21 KDM2B FGD5 MTF2 RBBP6 PHF12 PHF7 SCAF11 | 8.27e-05 | 449 | 242 | 17 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | BRPF3 UBE4B MYCBP2 ZMYND8 ASH1L KMT2E MAP3K1 BRAP KMT2C ZFYVE21 KDM2B FGD5 MTF2 RBBP6 PHF12 PHF7 SCAF11 | 1.08e-04 | 459 | 242 | 17 | IPR013083 |
| Domain | BROMODOMAIN_1 | 1.09e-04 | 37 | 242 | 5 | PS00633 | |
| Domain | cwf21 | 1.67e-04 | 2 | 242 | 2 | PF08312 | |
| Domain | Dynein1_light_intermed_chain | 1.67e-04 | 2 | 242 | 2 | IPR008467 | |
| Domain | mRNA_splic_Cwf21_dom | 1.67e-04 | 2 | 242 | 2 | IPR013170 | |
| Domain | Zinc_finger_PHD-type_CS | 1.94e-04 | 65 | 242 | 6 | IPR019786 | |
| Domain | Bromodomain_CS | 3.28e-04 | 26 | 242 | 4 | IPR018359 | |
| Domain | HRDC | 4.97e-04 | 3 | 242 | 2 | SM00341 | |
| Domain | Dynein_light_int_chain | 4.97e-04 | 3 | 242 | 2 | IPR022780 | |
| Domain | HRDC | 4.97e-04 | 3 | 242 | 2 | PS50967 | |
| Domain | SPAR_C | 4.97e-04 | 3 | 242 | 2 | PF11881 | |
| Domain | HRDC | 4.97e-04 | 3 | 242 | 2 | PF00570 | |
| Domain | MAP1 | 4.97e-04 | 3 | 242 | 2 | IPR026074 | |
| Domain | SIPA1L_C | 4.97e-04 | 3 | 242 | 2 | IPR021818 | |
| Domain | DLIC | 4.97e-04 | 3 | 242 | 2 | PF05783 | |
| Domain | FHA_DOMAIN | 6.57e-04 | 31 | 242 | 4 | PS50006 | |
| Domain | P-loop_NTPase | MCM8 MYO5A VWA8 KIF26A LSG1 CHD1 HELB BLM KIF9 DDX46 NAV3 NAV2 TJP2 KIF3C DYNC1H1 DYNC1LI2 SMARCAL1 MYO18A DNM1L ARHGAP35 KIF3A SMARCA4 DYNC1LI1 | 6.91e-04 | 848 | 242 | 23 | IPR027417 |
| Domain | MARK/par1 | 9.86e-04 | 4 | 242 | 2 | IPR033624 | |
| Domain | HRDC_dom | 9.86e-04 | 4 | 242 | 2 | IPR002121 | |
| Domain | WH2 | 1.06e-03 | 16 | 242 | 3 | PF02205 | |
| Domain | - | 1.17e-03 | 36 | 242 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 1.17e-03 | 36 | 242 | 4 | IPR000253 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG UBE4B MYCBP2 ZMYND8 HMGN1 ZNF318 GPATCH8 GPRIN1 TRIP12 CIC BLM FBXO38 TLK1 SAFB DDX46 SVIL MKI67 TJP2 KDM2B OXSR1 NIPBL CNOT3 DYNC1LI2 NCAPD3 RBM15 SRSF5 RBBP6 PHF12 NUMA1 MYO18A NIBAN2 ARHGAP35 TFAP4 PALB2 ESF1 NCOR2 ZNF106 MAP1S SIPA1L1 MDC1 SMARCA4 DYNC1LI1 SCAF11 MARK2 SRRM2 TP53BP1 SON | 1.03e-29 | 774 | 248 | 47 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG DENND4A ABL1 MAP1B MYCBP2 LSG1 SIPA1L3 C19orf47 CDK14 TRIP12 CIC LUZP1 FSIP2 USP31 DLC1 MTUS1 PI4KA SVIL NAV2 TJP2 JCAD RBM15 CDC42BPA COBLL1 NCKIPSD DNM1L FRYL SRGAP2 CEP192 PTPN21 ZNF106 C2CD3 SH3PXD2A SIPA1L1 ANKRD11 USP54 MARK2 SRRM2 PALLD CEP170B EXOC4 | 5.74e-22 | 861 | 248 | 41 | 36931259 |
| Pubmed | MAP1B INCENP MYO5A MYCBP2 CHD1 ZNF318 TRIP12 DNTTIP2 BLM DDX46 GLYR1 MCM3AP MKI67 TJP2 NIPBL PHIP DYNC1H1 RBM15 EXOSC10 SRSF5 COPB1 POLDIP3 U2SURP NUMA1 FRYL LARP7 ESF1 MDC1 SMARCA4 SCAF11 MPHOSPH10 SRRM2 TP53BP1 SON | 1.65e-19 | 653 | 248 | 34 | 22586326 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MAP1B INCENP ZMYND8 HMGN1 CHD1 ZNF318 TRIP12 CIC DNTTIP2 LUZP1 BLM SAFB DDX46 BBX BRCA2 MKI67 C2orf49 NIPBL PHIP NPAT RBM15 EXOSC10 RBBP6 POLDIP3 U2SURP ZNF280C NUMA1 POU4F3 RFX5 ESF1 NCOR2 ZZZ3 MDC1 ANKRD11 SMARCA4 SCAF11 MPHOSPH10 SRRM2 TP53BP1 SON | 1.77e-19 | 954 | 248 | 40 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VRK3 ZMYND8 HMGN1 ZNF318 GPATCH8 TRIP12 CIC DNTTIP2 BLM KMT2C SAFB DDX46 BBX GLYR1 ANAPC2 MKI67 KDM2B USF1 NIPBL CASP8AP2 TICRR NCAPD3 RBM15 EXOSC10 SRSF5 MTF2 RBBP6 POLDIP3 PHF12 U2SURP NUMA1 ZFC3H1 RFX5 TFAP4 PALB2 NCOR2 ZNF106 ZZZ3 MDC1 ANKRD11 SMARCA4 SCAF11 SRRM2 SON | 6.17e-18 | 1294 | 248 | 44 | 30804502 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP1B INCENP MYO5A MYCBP2 C19orf47 SRPK2 TRIP12 DNTTIP2 MAP3K1 BLM DDX46 GLYR1 MKI67 AP3D1 TICRR NCAPD3 RBM15 EXOSC10 SRSF5 RBBP6 POLDIP3 NUMA1 MYO18A ZFC3H1 LARP7 ESF1 POLR3B SMARCA4 SCAF11 MPHOSPH10 MARK2 LRRFIP2 SON EXOC4 | 1.62e-17 | 759 | 248 | 34 | 35915203 |
| Pubmed | LSG1 ZMYND8 PACSIN3 SRPK2 CHD1 TRIP12 DNTTIP2 LUZP1 SAFB DDX46 GLYR1 MKI67 TJP2 NCAPD3 RBM15 EXOSC10 CDC42BPA SRSF5 RBBP6 POLDIP3 U2SURP NUMA1 NIBAN2 ZFC3H1 TFAP4 LARP7 MDC1 SMARCA4 SCAF11 MPHOSPH10 SRRM2 LRRFIP2 SON | 2.82e-15 | 847 | 248 | 33 | 35850772 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DENND4A MYCBP2 SIPA1L3 SRPK2 TRIP12 FAT1 SAFB DDX46 TJP2 RBM15 SRSF5 ANK3 RBBP6 POLDIP3 PPFIBP2 ZDHHC5 ZFC3H1 MAP1S MDC1 SRRM2 PALLD SON | 2.32e-14 | 361 | 248 | 22 | 26167880 |
| Pubmed | DTD1 VRK3 VWA8 LSG1 SIPA1L3 PACSIN3 SRPK2 HMGN1 TRIP12 MAP3K1 LUZP1 DDX46 GLYR1 MCM3AP SVIL MKI67 TJP2 PIPSL C2orf49 AP3D1 DYNC1H1 RBM15 EXOSC10 CDC42BPA SRSF5 COPB1 POLDIP3 COBLL1 SMARCAL1 NUMA1 SAE1 NPLOC4 LARP7 ANKRD36B CUTC SMARCA4 SCAF11 MARK2 LRRFIP2 SON | 3.70e-14 | 1371 | 248 | 40 | 36244648 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | VRK3 INCENP CHD1 GPATCH8 TRIP12 CIC DNTTIP2 BLM FSIP2 FBXO38 BBX GLYR1 MKI67 KDM2B USF1 NIPBL PHIP BRWD1 NPAT MTF2 PHF12 ZNF280C NUMA1 RFX5 MDC1 SMARCA4 SCAF11 | 5.18e-14 | 608 | 248 | 27 | 36089195 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP1B INCENP MYO5A UBE4B MYCBP2 LSG1 CHD1 TRIP12 DNTTIP2 LUZP1 BLM SAFB PI4KA GLYR1 MCM3AP MKI67 NIPBL PHIP AP3D1 DYNC1H1 FNDC3B RBM15 EXOSC10 COPB1 POLDIP3 U2SURP NUMA1 SAE1 ESF1 NCOR2 POLR3B MDC1 SMARCA4 DYNC1LI1 SRRM2 PALLD TP53BP1 SON EXOC4 | 1.18e-13 | 1353 | 248 | 39 | 29467282 |
| Pubmed | BRPF3 PPP2R2D VWA8 KIF26A CDK14 KMT2C DDX46 MTUS1 ANAPC2 NAV2 KDM2B OXSR1 CRAMP1 ACAP3 CASP8AP2 NCAPD3 NYAP2 CDC42BPA PHF12 ZNF280C NPLOC4 MDC1 ROBO2 PCNX1 SCAF11 | 1.18e-13 | 529 | 248 | 25 | 14621295 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG MAP1B LSG1 ZMYND8 CHD1 ZNF318 GPRIN1 CIC DNTTIP2 BRAP SAFB DDX46 MKI67 NIPBL AP3D1 EXOSC10 COPB1 RBBP6 POLDIP3 U2SURP ZNF280C NUMA1 DNM1L SRGAP2 NIBAN2 ARHGAP35 NPLOC4 ESF1 SMARCA4 PALLD TP53BP1 SON | 2.54e-13 | 934 | 248 | 32 | 33916271 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ZMYND8 ZNF318 TRIP12 DNTTIP2 BLM DDX46 BBX GLYR1 MKI67 ACAP3 EXOSC10 RBBP6 POLDIP3 ZNF280C NUMA1 ESF1 MDC1 SMARCA4 SCAF11 | 2.60e-13 | 283 | 248 | 19 | 30585729 |
| Pubmed | SYNRG MAP1B MYCBP2 ZNF318 GPRIN1 LUZP1 BRAP KMT2C DDX46 AMOTL1 TJP2 KDM2B DYNC1H1 EXOSC10 ANK3 RBBP6 NUMA1 ARHGAP35 ESF1 ZZZ3 MDC1 SMARCA4 PALLD TP53BP1 EXOC4 | 2.70e-13 | 549 | 248 | 25 | 38280479 | |
| Pubmed | WIPF3 ZNF318 CIC LUZP1 TLK1 DDX46 MKI67 DYNC1H1 RBBP6 COBLL1 U2SURP NUMA1 DNM1L ARHGAP35 ATP8B2 LARP7 ESF1 ZZZ3 MDC1 SMARCA4 SRRM2 TP53BP1 LRRFIP2 SON | 3.48e-13 | 506 | 248 | 24 | 30890647 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POU6F2 MCM8 MAP1B MYO5A UBE4B MYCBP2 ATXN7L1 SIPA1L3 TMC6 ASH1L EVC SRPK2 ATP8B1 CDK14 KMT2C TLK1 GLYR1 OXSR1 CRAMP1 NPAS2 CDC42BPA ANK3 PPFIBP2 AFF3 FRYL SRGAP2 CEP192 ARHGAP35 TMEM255B TFAP4 NPLOC4 NCOR2 SH3PXD2A ANKRD11 LRP1 ZFHX2 SCAF11 PCDH1 CEP170B EXOC4 | 5.16e-13 | 1489 | 248 | 40 | 28611215 |
| Pubmed | VRK3 MYO5A LSG1 SIPA1L3 ZMYND8 PACSIN3 GON4L SRPK2 CHD1 ZNF318 GPATCH8 CIC LUZP1 BLM KMT2C DDX46 BBX PI4KA KDM2B CRYBG1 NIPBL CNOT3 FNDC3B NCAPD3 CDC42BPA TBC1D30 RBBP6 PHF12 SRGAP2 ZFC3H1 LARP7 ESF1 SIPA1L1 MDC1 ANKRD11 SCAF11 MPHOSPH10 MARK2 CEP170B SON | 6.11e-13 | 1497 | 248 | 40 | 31527615 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MAP1B MYCBP2 VWA8 MARK1 LSG1 ZMYND8 HMGN1 GPATCH8 TRIP12 BLM ZMAT5 SAFB DDX46 BBX GLYR1 NIPBL AP3D1 DYNC1H1 DYNC1LI2 NPAS2 RBM15 EXOSC10 CDC42BPA SRSF5 RBBP6 POLDIP3 U2SURP MYO18A ARHGAP35 SMARCA4 DYNC1LI1 SRRM2 SON | 2.47e-12 | 1082 | 248 | 33 | 38697112 |
| Pubmed | MYO5A ATXN7L1 ZMYND8 GON4L ZNF318 GPATCH8 CIC BLM KMT2C FAT1 BBX GLYR1 SVIL MKI67 KDM2B NIPBL CNOT3 DYNC1H1 NPAT CDC42BPA COPB1 RBBP6 POLDIP3 PHF12 NUMA1 MYO18A CEP192 RFX5 TFAP4 NCOR2 ZZZ3 MDC1 SMARCA4 SCAF11 USP54 SRRM2 TP53BP1 EXOC4 | 2.88e-12 | 1429 | 248 | 38 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG ABL1 UBE4B MYCBP2 VWA8 KIF26A SIPA1L3 TMC6 C19orf47 CIC KMT2C TLK1 FAT1 PI4KA MCM3AP NAV2 AP3D1 CRAMP1 DYNC1H1 CDC42BPA PHF12 DOCK9 ZDHHC5 FRYL SRGAP2 CEP192 ARHGAP35 NCOR2 C2CD3 MAP1S ANKRD11 PCNX1 CEP170B | 4.33e-12 | 1105 | 248 | 33 | 35748872 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | SIPA1L3 ZNF318 MCM3AP SVIL MKI67 RBBP6 U2SURP CEP192 RFX5 NCOR2 C2CD3 SIPA1L1 LRP1 PALLD CEP170B | 5.61e-12 | 184 | 248 | 15 | 32908313 |
| Pubmed | BRPF3 MCM8 VWA8 ATXN7L1 LSG1 ZMYND8 ASH1L SRPK2 ZNF318 ZC3H3 DNTTIP2 LUZP1 FAT1 MTUS1 MCM3AP PHIP BRWD1 RBBP6 PHF12 FAT3 LARP7 NCOR2 ZZZ3 TNFSF13B SIPA1L1 LRP1 SMARCA4 CLMP BICRAL USP54 SRRM2 CEP170B SON | 5.64e-12 | 1116 | 248 | 33 | 31753913 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TSPOAP1 INPP5D ZMYND8 KMT2E TRIP12 CIC MAP3K1 OXSR1 DYNC1H1 JCAD ANK3 RBBP6 PPFIBP2 NUMA1 GLIS3 SH3D21 NCOR2 MAP1S EGR2 MDC1 SON | 6.39e-12 | 430 | 248 | 21 | 35044719 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DTD1 INCENP MYO5A LSG1 SIPA1L3 PACSIN3 SRPK2 TRIP12 DNTTIP2 LUZP1 KRT80 SAFB GLYR1 SVIL AMOTL1 MKI67 TJP2 CRYBG1 DYNC1H1 RBM15 EXOSC10 COL17A1 RBBP6 POLDIP3 NUMA1 MYO18A ZFC3H1 ESF1 SIPA1L1 MDC1 SMARCA4 SCAF11 MPHOSPH10 MARK2 LRRFIP2 | 6.47e-12 | 1257 | 248 | 35 | 36526897 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | MAP1B MYO5A MARK1 GPRIN1 LUZP1 TJP2 AP3D1 BRWD1 SGIP1 TPPP ARHGAP35 SIPA1L1 DYNC1LI1 MARK2 SRRM2 CEP170B | 1.30e-11 | 231 | 248 | 16 | 16452087 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | INCENP PPP2R2D SIPA1L3 PACSIN3 BLM FBXO38 TLK1 DDX46 SVIL ANAPC2 MKI67 NIPBL CNOT3 DYNC1H1 DYNC1LI2 SRSF5 COPB1 POLDIP3 U2SURP NUMA1 TSEN54 CEP192 NIBAN2 LARP7 ZNF106 MAP1S SMARCA4 DYNC1LI1 MARK2 CEP170B TP53BP1 LRRFIP2 EXOC4 | 1.40e-11 | 1155 | 248 | 33 | 20360068 |
| Pubmed | GPRASP1 MYO5A MYCBP2 LSG1 SIPA1L3 SRPK2 ZNF318 LUZP1 PI4KA SVIL UNC79 NIPBL DYNC1H1 NYAP2 SGIP1 ANK3 NRCAM PRR36 NUMA1 TPPP DNM1L SRGAP2 KIF3A NCOR2 SIPA1L1 LRP1 SMARCA4 CEP170B TP53BP1 LRRFIP2 | 1.59e-11 | 963 | 248 | 30 | 28671696 | |
| Pubmed | MYCBP2 INPP5D ZMYND8 HMGN1 ZNF318 CIC KMT2C TLK1 SAFB MKI67 BIN2 USF1 C2orf49 NIPBL DYNC1H1 NCAPD3 RBM15 EXOSC10 POLDIP3 PHF12 U2SURP TOGARAM2 SAE1 RFX5 TFAP4 PALB2 NCOR2 SMARCA4 DYNC1LI1 BICRAL SRRM2 TP53BP1 | 1.99e-11 | 1103 | 248 | 32 | 34189442 | |
| Pubmed | MYO5A PPP2R2D MYCBP2 SIPA1L3 EYA2 GPRIN1 SNX19 CIC LUZP1 BLM USP31 FBXO38 MTUS1 PI4KA GLYR1 SVIL MKI67 JCAD RBM15 CDC42BPA ANK3 ZNF280C ZDHHC5 CEP192 NIBAN2 PTPN21 ESF1 CNNM1 NCOR2 C2CD3 SRRM2 | 2.67e-11 | 1049 | 248 | 31 | 27880917 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ZMYND8 GPATCH8 FBXO38 SAFB NIPBL DYNC1H1 NCAPD3 EXOSC10 NUMA1 SAE1 DNM1L NIBAN2 MDC1 SMARCA4 SCAF11 SRRM2 PALLD TP53BP1 | 3.94e-11 | 332 | 248 | 18 | 32786267 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG C19orf47 ZNF318 CIC LUZP1 BRAP BLM BRCA2 PI4KA MCM3AP KDM2B CNOT3 CASP8AP2 RBM15 RBBP6 POLDIP3 CEP192 NCOR2 ZZZ3 CFAP44 CEP170B TP53BP1 EXOC4 | 5.35e-11 | 588 | 248 | 23 | 38580884 |
| Pubmed | MAP1B MYO5A MARK1 SIPA1L3 SRPK2 LUZP1 USP31 SAFB PI4KA SVIL SORCS2 TJP2 AP3D1 DYNC1H1 SGIP1 SRSF5 ANK3 NRCAM COPB1 PRR36 NCKIPSD MYO18A TPPP DNM1L SRGAP2 ARHGAP35 KIF3A MAP1S SIPA1L1 SMARCA4 USP54 MARK2 PCDH1 CEP170B LRRFIP2 EXOC4 | 5.42e-11 | 1431 | 248 | 36 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MAP1B MYO5A MYCBP2 C19orf47 PACSIN3 CHD1 ZNF318 TRIP12 DNTTIP2 KRT80 SAFB DDX46 PI4KA SVIL MKI67 TJP2 NIPBL PHIP DYNC1H1 RBM15 EXOSC10 COPB1 POLDIP3 U2SURP NUMA1 MDC1 SMARCA4 MARK2 SRRM2 SON | 7.06e-11 | 1024 | 248 | 30 | 24711643 |
| Pubmed | INCENP ZMYND8 HMGN1 CHD1 GPATCH8 BLM SAFB DDX46 MKI67 OXSR1 NIPBL CASP8AP2 RBM15 EXOSC10 RBBP6 POLDIP3 SMARCAL1 NUMA1 SAE1 DNM1L TFAP4 NPLOC4 LARP7 ESF1 NCOR2 POLR3B MDC1 SMARCA4 SON | 2.62e-10 | 1014 | 248 | 29 | 32416067 | |
| Pubmed | INCENP TRIP12 DNTTIP2 GLYR1 MCM3AP SVIL MKI67 PHIP RBM15 EXOSC10 POLDIP3 NUMA1 LARP7 ESF1 MPHOSPH10 LRRFIP2 SON | 3.36e-10 | 332 | 248 | 17 | 25693804 | |
| Pubmed | VRK3 SIPA1L3 SRPK2 TRIP12 LUZP1 BRAP SVIL MKI67 KDM2B OXSR1 CNOT3 DYNC1H1 DYNC1LI2 RBM15 CDC42BPA SRSF5 COPB1 RBBP6 POLDIP3 PPFIBP2 U2SURP NUMA1 SAE1 LARP7 ESF1 KIF3A NCOR2 SIPA1L1 MPHOSPH10 MARK2 SRRM2 LRRFIP2 | 4.36e-10 | 1247 | 248 | 32 | 27684187 | |
| Pubmed | TRIP12 BLM SAFB ANAPC2 MKI67 NAV2 TJP2 NIPBL DYNC1LI2 RBM15 RBBP6 COBLL1 NUMA1 NIBAN2 MARK2 SRRM2 PALLD TP53BP1 SON EXOC4 | 7.66e-10 | 503 | 248 | 20 | 16964243 | |
| Pubmed | ATXN7L1 CHD1 ZNF318 BLM BRCA2 NIPBL NCAPD3 RBM15 POLDIP3 AFF3 ZFC3H1 ESF1 ZNF106 SMARCA4 | 8.72e-10 | 222 | 248 | 14 | 37071664 | |
| Pubmed | GPRASP1 SYNRG MAP1B MYO5A MYCBP2 VWA8 TSPOAP1 MARK1 GPRIN1 SAFB PI4KA GLYR1 NAV3 TJP2 CNOT3 JCAD NYAP2 SGIP1 CDC42BPA ANK3 NRCAM DOCK9 U2SURP MYO18A ARHGAP35 MAP1S SIPA1L1 DYNC1LI1 CEP170B TP53BP1 | 8.78e-10 | 1139 | 248 | 30 | 36417873 | |
| Pubmed | GPRASP1 MYO5A UBE4B MYCBP2 SIPA1L3 ZMYND8 ASH1L SRPK2 TRIP12 CREBZF NAV3 NIPBL CNOT3 DYNC1H1 BRWD1 JCAD ANK3 NRCAM COPB1 SRGAP2 ZFC3H1 RFX5 KIF3A POLR3B MAP1S SIPA1L1 LRP1 SMARCA4 ANKRD36 USP54 TNKS2 EXOC4 | 9.11e-10 | 1285 | 248 | 32 | 35914814 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | MYCBP2 KIF26A MARK1 ZNF318 MTUS1 SVIL AMOTL1 MKI67 RBM15 SRSF5 PHF12 NUMA1 ZFC3H1 NPLOC4 SRRM2 LRRFIP2 SON | 1.20e-09 | 361 | 248 | 17 | 30344098 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TRIP12 BLM DDX46 ANAPC2 OXSR1 NIPBL DYNC1H1 DYNC1LI2 RBM15 EXOSC10 SRSF5 COPB1 U2SURP DNM1L NIBAN2 NCOR2 SMARCA4 DYNC1LI1 MARK2 SRRM2 EXOC4 | 1.61e-09 | 582 | 248 | 21 | 20467437 |
| Pubmed | MYCBP2 ZMYND8 ASH1L PPP1R15A TRIP12 SVEP1 CREBZF MCM3AP ANAPC2 DYNC1H1 ANK3 MTF2 RBBP6 NIBAN2 NCOR2 ZNF106 LRP1 MPHOSPH10 TNKS2 PCDH1 SON | 2.11e-09 | 591 | 248 | 21 | 15231748 | |
| Pubmed | INCENP LSG1 ZNF318 GPRIN1 TRIP12 BLM FAT1 BBX PI4KA AMOTL1 MKI67 TJP2 AP3D1 DYNC1H1 DYNC1LI2 FAT4 EXOSC10 CDC42BPA ANK3 COPB1 ZDHHC5 DNM1L CEP192 ESF1 | 2.28e-09 | 777 | 248 | 24 | 35844135 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | MAP1B SAFB DDX46 MKI67 POLDIP3 U2SURP NUMA1 NCOR2 SCAF11 SRRM2 SON | 2.67e-09 | 130 | 248 | 11 | 35545047 |
| Pubmed | MYO5A SIPA1L3 PACSIN3 TRIP12 DNTTIP2 LUZP1 KRT80 SAFB DDX46 PI4KA SVIL MKI67 RBM15 SRSF5 POLDIP3 U2SURP NUMA1 MYO18A ZDHHC5 SRGAP2 MDC1 SRRM2 | 2.78e-09 | 660 | 248 | 22 | 32780723 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MYCBP2 LSG1 SRPK2 ZNF318 GPATCH8 TRIP12 DNTTIP2 BLM MKI67 EXOSC10 NUMA1 ZFC3H1 ESF1 MDC1 SMARCA4 MPHOSPH10 USP54 TP53BP1 | 3.57e-09 | 440 | 248 | 18 | 34244565 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | SRPK2 HMGN1 MAP3K1 SAFB ANAPC2 MKI67 C2orf49 DYNC1H1 NCAPD3 SRSF5 PHF12 U2SURP NUMA1 ZDHHC5 TSEN54 LARP7 KIF3A MDC1 SCAF11 SRRM2 PALLD TP53BP1 | 3.65e-09 | 670 | 248 | 22 | 22990118 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ZMYND8 GPRIN1 TRIP12 BLM KMT2C DDX46 NAV2 TJP2 AP3D1 RBM15 ANK3 DOCK9 U2SURP NUMA1 TOGARAM2 ZNF106 MAP1S ANKRD11 MARK2 | 3.91e-09 | 497 | 248 | 19 | 36774506 |
| Pubmed | DENND4A MARK1 SIPA1L3 LUZP1 AMOTL1 TJP2 JCAD RBM15 NCKIPSD FRYL SRGAP2 CEP192 MAP1S SH3PXD2A SIPA1L1 USP54 MARK2 CEP170B | 4.40e-09 | 446 | 248 | 18 | 24255178 | |
| Pubmed | MAP1B MYO5A MYCBP2 PACSIN3 GPRIN1 DYNC1LI2 SGIP1 NRCAM DOCK9 MYO18A ZDHHC5 SH3PXD2A SIPA1L1 MARK2 SRRM2 CEP170B | 5.05e-09 | 347 | 248 | 16 | 17114649 | |
| Pubmed | MARK1 ASH1L ZNF318 GPATCH8 TRIP12 DNTTIP2 KMT2C PI4KA GLYR1 TJP2 CRYBG1 BIN2 DYNC1LI2 BRWD1 NPAT TICRR EXOSC10 ANK3 DOCK9 DNM1L FRYL SRGAP2 CEP192 ESF1 SIPA1L1 MPHOSPH10 TP53BP1 LRRC71 | 5.10e-09 | 1084 | 248 | 28 | 11544199 | |
| Pubmed | MAP1B ZNF318 GPATCH8 FSIP2 SAFB MKI67 DYNC1LI2 RBBP6 NUMA1 SAE1 NCOR2 MDC1 DYNC1LI1 SRRM2 PALLD TP53BP1 SON | 5.38e-09 | 399 | 248 | 17 | 35987950 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ABL1 MAP1B INCENP PPP2R2D MARK1 CHD1 GPATCH8 CDK14 DNTTIP2 MAP3K1 LUZP1 ANAPC2 CDC42BPA SRSF5 AFF3 CEP192 ESF1 ANKRD36B NCOR2 CD4 MAP1S SH3PXD2A ANKRD36 MARK2 PALLD | 1.08e-08 | 910 | 248 | 25 | 36736316 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DTD1 ABI3 PPP2R2D LSG1 PACSIN3 SAFB DDX46 PI4KA NAV3 PHIP AP3D1 EXOSC10 LARP7 KIF3A NCOR2 SIPA1L1 DYNC1LI1 TP53BP1 | 1.16e-08 | 475 | 248 | 18 | 31040226 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ZMYND8 ASH1L HMGN1 CHD1 TRIP12 DNTTIP2 BBX MKI67 NIPBL PHIP DYNC1H1 COPB1 POLDIP3 NUMA1 POLR3B MDC1 SMARCA4 DYNC1LI1 SRRM2 | 1.21e-08 | 533 | 248 | 19 | 30554943 |
| Pubmed | SIPA1L3 LUZP1 SAFB SVIL TJP2 JCAD CDC42BPA RBBP6 MYO18A LARP7 ESF1 SIPA1L1 SMARCA4 MARK2 | 1.30e-08 | 274 | 248 | 14 | 34244482 | |
| Pubmed | MYO5A GON4L TRIP12 FBXO38 RBM15 EXOSC10 CDC42BPA FAT3 COBLL1 NUMA1 MDC1 SMARCA4 SRRM2 | 1.61e-08 | 234 | 248 | 13 | 36243803 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | TRIP12 DNTTIP2 DDX46 MKI67 AP3D1 DYNC1H1 EXOSC10 COPB1 U2SURP | 1.76e-08 | 90 | 248 | 9 | 35654790 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | MYO5A UBE4B GPRIN1 LUZP1 PI4KA DYNC1H1 ANK3 NRCAM DNM1L SRGAP2 SIPA1L1 DYNC1LI1 PCDH1 CEP170B | 1.78e-08 | 281 | 248 | 14 | 28706196 |
| Pubmed | 2.18e-08 | 13 | 248 | 5 | 29499138 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYO5A LSG1 DNTTIP2 LUZP1 SAFB DDX46 GLYR1 SVIL MKI67 AP3D1 DYNC1H1 RBM15 COPB1 RBBP6 POLDIP3 U2SURP NUMA1 MYO18A MDC1 SMARCA4 MPHOSPH10 MARK2 SRRM2 LRRFIP2 SON | 2.44e-08 | 949 | 248 | 25 | 36574265 |
| Pubmed | MYO5A MYCBP2 VWA8 LSG1 SRPK2 CHD1 GPRIN1 SNX19 DNTTIP2 BRAP BLM USP31 PI4KA GLYR1 AP3D1 NPAT CASP8AP2 EXOSC10 CDC42BPA ANK3 MYO18A ZDHHC5 CEP192 NIBAN2 ZFC3H1 LARP7 ESF1 ANKRD11 MARK2 SRRM2 TP53BP1 EXOC4 | 2.93e-08 | 1487 | 248 | 32 | 33957083 | |
| Pubmed | MYO5A VWA8 LSG1 SIPA1L3 GPATCH8 BRCA2 PI4KA SVIL MKI67 NAV2 SRSF5 ANK3 MTF2 MYO18A PALB2 LARP7 ZNF106 LRP1 SMARCA4 SCAF11 | 3.72e-08 | 634 | 248 | 20 | 34591612 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DENND4A INCENP LSG1 CHD1 DNTTIP2 SAFB PI4KA GLYR1 MKI67 FGD5 KIF3C NIPBL PHIP DYNC1H1 NPAS2 NCAPD3 RBM15 SRSF5 COPB1 POLDIP3 U2SURP ZNF280C NUMA1 DNM1L LARP7 ESF1 MDC1 SMARCA4 DYNC1LI1 SRRM2 LRRFIP2 | 3.86e-08 | 1425 | 248 | 31 | 30948266 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | VRK3 MAP1B TRIP12 DNTTIP2 SAFB GLYR1 MKI67 PHIP EXOSC10 NUMA1 TFAP4 LARP7 MDC1 MPHOSPH10 SRRM2 | 3.89e-08 | 349 | 248 | 15 | 25665578 |
| Pubmed | SYNRG DENND4A LSG1 SIPA1L3 LUZP1 HELB MTUS1 CEP192 ARHGAP35 SIPA1L1 PALLD CEP170B | 4.03e-08 | 209 | 248 | 12 | 36779422 | |
| Pubmed | INCENP GPATCH8 BLM MKI67 NIPBL NCAPD3 PHF12 NUMA1 ESF1 DYNC1LI1 SRRM2 SON | 4.25e-08 | 210 | 248 | 12 | 16565220 | |
| Pubmed | UBE4B TSPOAP1 GON4L GPATCH8 SNX19 USP31 MCM3AP NAV3 DYNC1H1 NRCAM DOCK9 CEP192 SIPA1L1 SRRM2 CEP170B SON | 4.67e-08 | 407 | 248 | 16 | 12693553 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MAP1B SRPK2 DNTTIP2 BBX PI4KA MKI67 NIPBL TICRR SRSF5 SMARCAL1 ZNF106 SIPA1L1 SCAF11 MPHOSPH10 MARK2 SON | 5.17e-08 | 410 | 248 | 16 | 26949251 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | INCENP LSG1 CHD1 GPATCH8 TRIP12 DNTTIP2 BLM SAFB GLYR1 MKI67 RBM15 EXOSC10 U2SURP ZNF280C NUMA1 ESF1 NCOR2 ZNF106 MDC1 SMARCA4 SCAF11 MPHOSPH10 SRRM2 TP53BP1 SON | 5.40e-08 | 989 | 248 | 25 | 36424410 |
| Pubmed | LUZP1 SAFB SVIL TJP2 NIPBL DYNC1H1 DYNC1LI2 RBM15 ZNF280C NUMA1 SRGAP2 SNCAIP DYNC1LI1 SRRM2 TP53BP1 | 5.83e-08 | 360 | 248 | 15 | 33111431 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SYNRG MAP1B MYO5A MYCBP2 LSG1 TRIP12 LUZP1 MKI67 TJP2 OXSR1 FNDC3B MYO18A SRGAP2 NIBAN2 ZFC3H1 ARHGAP35 SH3PXD2A MPHOSPH10 PALLD SON EXOC4 | 6.94e-08 | 724 | 248 | 21 | 36232890 |
| Pubmed | SRPK2 CHD1 TRIP12 LUZP1 GLYR1 AP3D1 DYNC1H1 EXOSC10 SRSF5 COPB1 POLDIP3 NUMA1 MYO18A SAE1 DNM1L SMARCA4 SCAF11 CEP170B EXOC4 | 7.98e-08 | 601 | 248 | 19 | 33658012 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | ZMYND8 DNTTIP2 SAFB MKI67 POLDIP3 ZNF280C ESF1 MDC1 MPHOSPH10 SON | 1.22e-07 | 148 | 248 | 10 | 32538781 |
| Pubmed | VWA8 DNTTIP2 BRCA2 PI4KA GLYR1 MKI67 KDM2B FGD5 DYNC1H1 JCAD CASP8AP2 RBM15 FAT4 MYO18A ARHGEF15 NCOR2 MDC1 SMARCA4 MPHOSPH10 LRRFIP2 EXOC4 | 1.36e-07 | 754 | 248 | 21 | 35906200 | |
| Pubmed | ABL1 EML6 ZMYND8 FAT1 GLYR1 SVIL AMOTL1 DYNC1H1 R3HCC1 NUMA1 SAE1 ANKRD11 SMARCA4 SON | 1.41e-07 | 332 | 248 | 14 | 37433992 | |
| Pubmed | VRK3 MAP1B ASH1L WIPF3 PACSIN3 ZNF318 CIC KMT2C FAT1 SVIL AMOTL1 FGD5 NCAPD3 POLDIP3 NCKIPSD DNM1L SRGAP2 ARHGAP35 NPLOC4 ROBO2 | 1.42e-07 | 689 | 248 | 20 | 36543142 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SIPA1L3 GPRIN1 LUZP1 PI4KA SVIL NAV2 TJP2 CRYBG1 JCAD COL17A1 ANK3 DOCK9 COBLL1 ZDHHC5 SRGAP2 NIBAN2 MARK2 PCDH1 | 1.58e-07 | 565 | 248 | 18 | 25468996 |
| Pubmed | 1.62e-07 | 116 | 248 | 9 | 30804394 | ||
| Pubmed | DENND4A MAP1B MYO5A LSG1 SLCO2B1 SIPA1L3 EML6 ASH1L ZNF318 TRIP12 DNTTIP2 LUZP1 TLK1 SAFB BBX NAV2 NIPBL AP3D1 U2SURP NUMA1 MYO18A ZFC3H1 PTPN21 SH3D21 PALB2 LARP7 ESF1 C2CD3 SH3PXD2A MPHOSPH10 | 1.70e-07 | 1442 | 248 | 30 | 35575683 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MAP1B ZMYND8 GON4L TRIP12 BLM GLYR1 COPB1 POLDIP3 U2SURP NUMA1 MDC1 DYNC1LI1 SCAF11 TP53BP1 EXOC4 | 1.87e-07 | 394 | 248 | 15 | 27248496 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | MYCBP2 ZMYND8 DNTTIP2 BBX SVIL MKI67 PHIP COPB1 PHF12 NCOR2 ANKRD11 SRRM2 SON | 1.89e-07 | 289 | 248 | 13 | 23752268 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | UBE4B ZMYND8 CHD1 DDX46 MCM3AP MKI67 AP3D1 NCAPD3 SRSF5 RBBP6 SMARCAL1 MDC1 SRRM2 TP53BP1 | 1.95e-07 | 341 | 248 | 14 | 32971831 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXR1 VRK3 MAP1B PPP2R2D ZMYND8 SRPK2 TRIP12 CIC BLM BBX PI4KA GLYR1 DYNC1H1 NCAPD3 SMARCAL1 TFAP4 LARP7 NCOR2 LRP1 SMARCA4 TP53BP1 LRRFIP2 | 2.73e-07 | 857 | 248 | 22 | 25609649 |
| Pubmed | MAP1B INCENP CHD1 TRIP12 MKI67 RBBP6 PALB2 SMARCA4 MPHOSPH10 SRRM2 TP53BP1 SON | 2.82e-07 | 250 | 248 | 12 | 33536335 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | GPRASP1 MAP1B PPP2R2D MYCBP2 VWA8 MARK1 TRIP12 FBXO38 SAFB AMOTL1 TJP2 RBM15 POLDIP3 CEP192 NIBAN2 TFAP4 NPLOC4 KIF3A POLR3B SIPA1L1 LRP1 MARK2 SRRM2 TP53BP1 | 2.84e-07 | 1005 | 248 | 24 | 19615732 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | VRK3 ZMYND8 C19orf47 CHD1 TRIP12 DNTTIP2 SAFB DDX46 MKI67 TJP2 CRYBG1 OXSR1 NIPBL PHIP AP3D1 DYNC1H1 RBM15 COPB1 RBBP6 U2SURP NUMA1 SAE1 DNM1L LARP7 SMARCA4 MPHOSPH10 SRRM2 SON | 2.99e-07 | 1318 | 248 | 28 | 30463901 |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 3.07e-07 | 125 | 248 | 9 | 21654808 | |
| Pubmed | Tyrosine kinase c-Abl couples RNA polymerase II transcription to DNA double-strand breaks. | 3.58e-07 | 3 | 248 | 3 | 30668775 | |
| Pubmed | A conserved interaction that is essential for the biogenesis of histone locus bodies. | 3.58e-07 | 3 | 248 | 3 | 25339177 | |
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 32722282 | ||
| Pubmed | MYCBP2 ZMYND8 ZNF318 CIC LUZP1 BRCA2 KDM2B NPAT CASP8AP2 PHF12 PALB2 NCOR2 ZZZ3 LRP1 EXOC4 | 3.97e-07 | 418 | 248 | 15 | 34709266 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ZMYND8 C19orf47 KRT80 SAFB DDX46 GLYR1 MKI67 RBM15 EXOSC10 SRSF5 POLDIP3 U2SURP NUMA1 LARP7 MDC1 SMARCA4 SCAF11 SRRM2 | 4.28e-07 | 605 | 248 | 18 | 28977666 |
| Pubmed | VWA8 ATXN7L1 TRIP12 MCM3AP COL17A1 NRCAM U2SURP SIPA1L1 BICRAL | 4.29e-07 | 130 | 248 | 9 | 12421765 | |
| Pubmed | KIF26A CIC KMT2C TLK1 MCM3AP NAV3 NAV2 CASP8AP2 CDC42BPA ANK3 RBBP6 COBLL1 MYO18A KIF3A ZNF106 BICRAL | 5.10e-07 | 486 | 248 | 16 | 20936779 | |
| Pubmed | 5.20e-07 | 67 | 248 | 7 | 29254152 | ||
| Pubmed | DENND4A MYCBP2 WIPF3 GON4L LRRC2 KMT2E DNTTIP2 FNDC3B EXOSC10 CDC42BPA DOCK9 GLIS3 KIF3A TNKS2 PALLD SON | 6.84e-07 | 497 | 248 | 16 | 23414517 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | VRK3 MAP1B MYO5A SIPA1L3 SRPK2 LUZP1 SAFB SVIL MKI67 TJP2 DYNC1H1 SRSF5 SMARCAL1 NUMA1 MYO18A SIPA1L1 SRRM2 LRRFIP2 | 6.99e-07 | 626 | 248 | 18 | 33644029 |
| Interaction | NUP43 interactions | INCENP ZMYND8 ASH1L GON4L CHD1 ZNF318 GPATCH8 TRIP12 DNTTIP2 HELB BLM FSIP2 SAFB BBX BRCA2 PI4KA GLYR1 MCM3AP MKI67 NIPBL PHIP NPAT CASP8AP2 RBM15 RBBP6 PHF12 ZNF280C ZFC3H1 LARP7 NCOR2 ZZZ3 MDC1 ANKRD11 SMARCA4 MPHOSPH10 SRRM2 SON | 1.18e-15 | 625 | 244 | 37 | int:NUP43 |
| Interaction | YWHAG interactions | SYNRG DENND4A ABL1 MYCBP2 MARK1 SIPA1L3 C19orf47 CDK14 TRIP12 CIC DNTTIP2 MAP3K1 LUZP1 LNP1 USP31 DLC1 MTUS1 PI4KA SVIL NAV2 TJP2 C2orf49 DYNC1H1 JCAD TICRR RBM15 CDC42BPA COPB1 PPFIBP2 DOCK9 COBLL1 NCKIPSD DNM1L FRYL SRGAP2 CEP192 PTPN21 ZNF106 C2CD3 SH3PXD2A TNFSF13B SIPA1L1 ANKRD11 SCAF11 USP54 MARK2 SRRM2 CEP170B SON EXOC4 | 4.44e-14 | 1248 | 244 | 50 | int:YWHAG |
| Interaction | YWHAZ interactions | SYNRG DENND4A ABL1 MYO5A PPP2R2D MYCBP2 MARK1 SIPA1L3 HMGN1 CDK14 TRIP12 CIC MAP3K1 LUZP1 LNP1 FSIP2 USP31 MTUS1 SVIL AMOTL1 NAV2 TJP2 C2orf49 DYNC1H1 JCAD FNDC3B TICRR NCAPD3 RBM15 CDC42BPA COPB1 PPFIBP2 TEDC2 DOCK9 COBLL1 NCKIPSD MYO18A DNM1L FRYL SRGAP2 CEP192 PTPN21 SH3PXD2A SIPA1L1 MDC1 DYNC1LI1 SCAF11 USP54 MARK2 CEP170B TP53BP1 | 9.37e-14 | 1319 | 244 | 51 | int:YWHAZ |
| Interaction | YWHAE interactions | SYNRG DENND4A ABL1 MAP1B MYCBP2 MARK1 SIPA1L3 CDK14 TRIP12 CIC MAP3K1 LUZP1 LNP1 USP31 TLK1 SVIL AMOTL1 NAV2 TJP2 FGF12 FGD5 C2orf49 DYNC1H1 JCAD TICRR RBM15 CDC42BPA PPFIBP2 DOCK9 COBLL1 NCKIPSD SAE1 DNM1L FRYL SRGAP2 PTPN21 NCOR2 ZNF106 SH3PXD2A SIPA1L1 DYNC1LI1 SCAF11 USP54 MARK2 SRRM2 CEP170B LRRFIP2 EXOC4 | 8.88e-13 | 1256 | 244 | 48 | int:YWHAE |
| Interaction | YWHAH interactions | SYNRG DENND4A ABL1 MYCBP2 MARK1 LSG1 SIPA1L3 C19orf47 CDK14 TRIP12 CIC LUZP1 LNP1 USP31 MTUS1 PI4KA SVIL NAV2 TJP2 JCAD TICRR RBM15 CDC42BPA PPFIBP2 DOCK9 COBLL1 NCKIPSD DNM1L FRYL SRGAP2 CEP192 PTPN21 ZNF106 C2CD3 SNCAIP SH3PXD2A SIPA1L1 ANKRD11 USP54 MARK2 SRRM2 PALLD CEP170B EXOC4 | 2.18e-12 | 1102 | 244 | 44 | int:YWHAH |
| Interaction | H3C1 interactions | INCENP ZMYND8 ASH1L HMGN1 CHD1 GPRIN1 TRIP12 DNTTIP2 BLM KMT2C TLK1 BBX GLYR1 MKI67 NAV3 NAV2 KDM2B BIN2 USF1 NIPBL PHIP DYNC1H1 FAT4 EXOSC10 ANK3 COBLL1 U2SURP ZNF280C NUMA1 MYO18A RFX5 PALB2 LARP7 MDC1 SMARCA4 PAX5 PALLD TP53BP1 | 1.74e-11 | 901 | 244 | 38 | int:H3C1 |
| Interaction | SMC5 interactions | MAP1B INCENP ZMYND8 HMGN1 CHD1 ZNF318 TRIP12 CIC DNTTIP2 LUZP1 BLM SAFB DDX46 BBX BRCA2 MKI67 C2orf49 NIPBL PHIP NPAT RBM15 EXOSC10 RBBP6 POLDIP3 U2SURP ZNF280C NUMA1 POU4F3 RFX5 ESF1 NCOR2 ZZZ3 MDC1 ANKRD11 SMARCA4 SCAF11 MPHOSPH10 SRRM2 TP53BP1 SON | 2.42e-11 | 1000 | 244 | 40 | int:SMC5 |
| Interaction | SIRT7 interactions | MAP1B INCENP MYO5A MYCBP2 CHD1 ZNF318 TRIP12 DNTTIP2 BLM DDX46 GLYR1 MCM3AP MKI67 TJP2 NIPBL PHIP DYNC1H1 RBM15 EXOSC10 SRSF5 COPB1 POLDIP3 U2SURP NUMA1 FRYL LARP7 ESF1 MDC1 SMARCA4 SCAF11 MPHOSPH10 SRRM2 TP53BP1 SON | 2.71e-11 | 744 | 244 | 34 | int:SIRT7 |
| Interaction | H2BC21 interactions | BRPF3 VRK3 MAP1B INCENP ATXN7L1 ZMYND8 CDK14 TRIP12 DNTTIP2 BLM GLYR1 SVIL MKI67 CRYBG1 NIPBL PHIP DYNC1H1 TICRR MTF2 PHF12 SMARCAL1 ZNF280C NUMA1 PALB2 LARP7 C2CD3 ZZZ3 MDC1 SMARCA4 SCAF11 SRRM2 LRRFIP2 | 9.45e-11 | 696 | 244 | 32 | int:H2BC21 |
| Interaction | TERF2IP interactions | INCENP ZMYND8 PACSIN3 CHD1 ZNF318 TRIP12 CIC BLM BBX BRCA2 MKI67 KDM2B NIPBL NPAT RBBP6 U2SURP ZNF280C NUMA1 RFX5 TFAP4 LARP7 NCOR2 ZZZ3 MDC1 ANKRD11 SMARCA4 SCAF11 SRRM2 | 1.70e-10 | 552 | 244 | 28 | int:TERF2IP |
| Interaction | YWHAQ interactions | SYNRG DENND4A ABL1 VRK3 MYCBP2 MARK1 SIPA1L3 C19orf47 CDK14 TRIP12 CIC MAP3K1 LUZP1 LNP1 USP31 MTUS1 SVIL NAV2 TJP2 FGD5 C2orf49 UNC79 DYNC1H1 JCAD TICRR CDC42BPA PPFIBP2 COBLL1 NCKIPSD NUMA1 DNM1L FRYL SRGAP2 CEP192 ZNF106 SH3PXD2A TNFSF13B SIPA1L1 USP54 MARK2 CEP170B | 1.89e-10 | 1118 | 244 | 41 | int:YWHAQ |
| Interaction | SNRNP40 interactions | GON4L SRPK2 CHD1 ZNF318 GPATCH8 DNTTIP2 BLM TLK1 BRCA2 MKI67 C2orf49 NPAT CASP8AP2 RBM15 RBBP6 POLDIP3 PHF12 SMARCAL1 ZNF280C NUMA1 ZFC3H1 LARP7 NCOR2 MDC1 SMARCA4 SCAF11 MPHOSPH10 TNKS2 SRRM2 SON | 2.17e-10 | 637 | 244 | 30 | int:SNRNP40 |
| Interaction | HECTD1 interactions | MAP1B INCENP MYO5A MYCBP2 C19orf47 SRPK2 TRIP12 DNTTIP2 MAP3K1 BLM DDX46 GLYR1 MKI67 AP3D1 TICRR NCAPD3 RBM15 EXOSC10 SRSF5 RBBP6 POLDIP3 U2SURP NUMA1 MYO18A SRGAP2 ZFC3H1 LARP7 ESF1 POLR3B SH3PXD2A ANKRD11 SMARCA4 SCAF11 MPHOSPH10 MARK2 LRRFIP2 SON EXOC4 | 2.24e-10 | 984 | 244 | 38 | int:HECTD1 |
| Interaction | SFN interactions | SYNRG DENND4A ABL1 MAP1B MYCBP2 MARK1 SIPA1L3 TRIP12 LUZP1 USP31 MTUS1 SVIL NAV2 TJP2 OXSR1 JCAD CDC42BPA PPFIBP2 COBLL1 DNM1L FRYL SRGAP2 CEP192 SH3PXD2A SIPA1L1 USP54 MARK2 SRRM2 PALLD CEP170B | 1.54e-09 | 692 | 244 | 30 | int:SFN |
| Interaction | YWHAB interactions | SYNRG DENND4A ABL1 MYCBP2 MARK1 SIPA1L3 SRPK2 CDK14 TRIP12 CIC LUZP1 LNP1 USP31 SVIL NAV2 TJP2 DYNC1H1 TICRR NCAPD3 CDC42BPA DOCK9 COBLL1 NCKIPSD DNM1L FRYL SRGAP2 CEP192 PTPN21 ZNF106 SH3PXD2A SIPA1L1 DYNC1LI1 USP54 MARK2 SRRM2 CEP170B SON | 1.89e-09 | 1014 | 244 | 37 | int:YWHAB |
| Interaction | MEN1 interactions | UBE4B LSG1 ZMYND8 PACSIN3 SRPK2 CHD1 TRIP12 DNTTIP2 LUZP1 KMT2C SAFB DDX46 BRCA2 GLYR1 MCM3AP MKI67 TJP2 AP3D1 NCAPD3 RBM15 EXOSC10 CDC42BPA SRSF5 RBBP6 SMARCAL1 U2SURP NUMA1 NIBAN2 ZFC3H1 TFAP4 MDC1 SMARCA4 SCAF11 MPHOSPH10 SRRM2 TP53BP1 SON | 2.80e-09 | 1029 | 244 | 37 | int:MEN1 |
| Interaction | ZNF330 interactions | INCENP ZMYND8 SRPK2 CHD1 GPATCH8 TRIP12 DNTTIP2 BLM BBX GLYR1 KDM2B NIPBL PHIP EXOSC10 MTF2 POLDIP3 ZNF280C ZFC3H1 LARP7 ESF1 ZNF106 ANKRD11 SMARCA4 | 5.87e-09 | 446 | 244 | 23 | int:ZNF330 |
| Interaction | DOT1L interactions | LSG1 ZMYND8 PACSIN3 SRPK2 CHD1 TRIP12 DNTTIP2 LUZP1 SAFB DDX46 GLYR1 MKI67 NCAPD3 RBM15 EXOSC10 CDC42BPA SRSF5 RBBP6 POLDIP3 U2SURP SRGAP2 ZFC3H1 TFAP4 LARP7 MDC1 SMARCA4 SCAF11 MPHOSPH10 SRRM2 LRRFIP2 SON | 1.39e-08 | 807 | 244 | 31 | int:DOT1L |
| Interaction | XRCC6 interactions | ABL1 VRK3 MAP1B ZMYND8 ZNF318 TRIP12 CIC DNTTIP2 BLM KIF9 DDX46 BBX BRCA2 GLYR1 MKI67 FGD5 USF1 ACAP3 EXOSC10 COPB1 RBBP6 POLDIP3 ZNF280C NUMA1 DNM1L LARP7 ESF1 MDC1 SMARCA4 DYNC1LI1 SCAF11 SRRM2 TP53BP1 | 2.91e-08 | 928 | 244 | 33 | int:XRCC6 |
| Interaction | H2BC8 interactions | INCENP LSG1 ZMYND8 GON4L HMGN1 CHD1 TRIP12 DNTTIP2 BLM BBX GLYR1 MKI67 KDM2B NIPBL PHIP EXOSC10 MTF2 ZNF280C NUMA1 RFX5 PALB2 ESF1 MDC1 SMARCA4 SCAF11 | 3.83e-08 | 576 | 244 | 25 | int:H2BC8 |
| Interaction | H3C3 interactions | INCENP CHD1 TRIP12 CIC DNTTIP2 BLM FSIP2 FBXO38 BBX GLYR1 MKI67 KDM2B NIPBL PHIP NPAT MTF2 PHF12 ZNF280C NUMA1 RFX5 MDC1 SMARCA4 SCAF11 | 4.05e-08 | 495 | 244 | 23 | int:H3C3 |
| Interaction | ANAPC15 interactions | ABL1 LSG1 DNTTIP2 SAFB DDX46 BBX ANAPC2 TJP2 U2SURP ZFC3H1 ESF1 SCAF11 | 5.20e-08 | 128 | 244 | 12 | int:ANAPC15 |
| Interaction | SUMO2 interactions | ZMYND8 HMGN1 GPATCH8 TRIP12 CIC BLM FBXO38 SAFB ANAPC2 MKI67 NIPBL DYNC1H1 CASP8AP2 NCAPD3 EXOSC10 NUMA1 SAE1 DNM1L NIBAN2 MDC1 SMARCA4 SCAF11 SRRM2 PALLD TP53BP1 | 6.29e-08 | 591 | 244 | 25 | int:SUMO2 |
| Interaction | H3-3A interactions | VRK3 INCENP ASH1L CHD1 GPATCH8 TRIP12 CIC DNTTIP2 BLM FBXO38 KMT2C BBX GLYR1 MKI67 KDM2B USF1 NIPBL PHIP BRWD1 NPAT ZNF280C NUMA1 NIBAN2 RFX5 CD4 MDC1 SMARCA4 SCAF11 | 1.30e-07 | 749 | 244 | 28 | int:H3-3A |
| Interaction | SLX4 interactions | INCENP ATXN7L1 CHD1 ZNF318 BLM SAFB DDX46 BRCA2 MKI67 NIPBL DYNC1H1 NCAPD3 RBM15 EXOSC10 POLDIP3 AFF3 NUMA1 ZFC3H1 ESF1 ZNF106 ZZZ3 MDC1 SMARCA4 TP53BP1 | 1.36e-07 | 572 | 244 | 24 | int:SLX4 |
| Interaction | POLR1G interactions | INCENP ZMYND8 CHD1 TRIP12 CIC DNTTIP2 BLM BBX KDM2B NIPBL PHIP EXOSC10 NUMA1 ZFC3H1 LARP7 ESF1 ZNF106 POLR3B ANKRD11 SMARCA4 MPHOSPH10 SRRM2 | 1.42e-07 | 489 | 244 | 22 | int:POLR1G |
| Interaction | SRPK2 interactions | ABL1 MYCBP2 SIPA1L3 SRPK2 GPATCH8 TRIP12 SAFB DDX46 GLYR1 MKI67 TJP2 FGF12 RBM15 SRSF5 ANK3 RBBP6 POLDIP3 U2SURP ZDHHC5 ZFC3H1 LARP7 MAP1S MDC1 SCAF11 SRRM2 PALLD SON | 1.91e-07 | 717 | 244 | 27 | int:SRPK2 |
| Interaction | LINC02910 interactions | LSG1 DNTTIP2 SAFB DDX46 TJP2 U2SURP ZFC3H1 ESF1 SCAF11 MPHOSPH10 | 2.31e-07 | 95 | 244 | 10 | int:LINC02910 |
| Interaction | NAA40 interactions | SYNRG MAP1B LSG1 ZMYND8 CHD1 ZNF318 GPRIN1 CIC DNTTIP2 BRAP SAFB DDX46 MKI67 NIPBL AP3D1 EXOSC10 COPB1 RBBP6 POLDIP3 U2SURP ZNF280C NUMA1 DNM1L SRGAP2 NIBAN2 ARHGAP35 NPLOC4 ESF1 SMARCA4 PALLD TP53BP1 SON | 3.16e-07 | 978 | 244 | 32 | int:NAA40 |
| Interaction | DHX40 interactions | ATXN7L1 CHD1 ZNF318 GPATCH8 BLM FBXO38 SAFB RBM15 RBBP6 POLDIP3 ZFC3H1 ESF1 ZNF106 ANKRD11 MPHOSPH10 | 4.05e-07 | 249 | 244 | 15 | int:DHX40 |
| Interaction | PYHIN1 interactions | MAP1B LSG1 SRPK2 CHD1 SAFB MKI67 CRYBG1 PHIP EXOSC10 U2SURP ZNF280C NUMA1 TFAP4 LARP7 MDC1 SMARCA4 MPHOSPH10 SRRM2 | 4.09e-07 | 358 | 244 | 18 | int:PYHIN1 |
| Interaction | TOP3B interactions | SYNRG ABL1 UBE4B MYCBP2 VWA8 KIF26A SIPA1L3 TMC6 C19orf47 HMGN1 CIC KMT2C TLK1 FAT1 SAFB PI4KA MCM3AP SVIL NAV2 AP3D1 CRAMP1 DYNC1H1 RBM15 CDC42BPA POLDIP3 PHF12 DOCK9 ZDHHC5 FRYL SRGAP2 CEP192 ARHGAP35 NCOR2 C2CD3 MAP1S MDC1 ANKRD11 PCNX1 CEP170B TP53BP1 EXOC4 | 4.30e-07 | 1470 | 244 | 41 | int:TOP3B |
| Interaction | IFI16 interactions | MAP1B INCENP SIPA1L3 TRIP12 DNTTIP2 SAFB GLYR1 MCM3AP SVIL MKI67 PHIP RBM15 EXOSC10 SRSF5 POLDIP3 U2SURP NUMA1 LARP7 ESF1 MDC1 MPHOSPH10 MARK2 SRRM2 TP53BP1 LRRFIP2 SON | 6.18e-07 | 714 | 244 | 26 | int:IFI16 |
| Interaction | ARL16 interactions | 7.27e-07 | 83 | 244 | 9 | int:ARL16 | |
| Interaction | GSK3A interactions | SYNRG DENND4A LSG1 SIPA1L3 SRPK2 HMGN1 LUZP1 HELB MTUS1 CRYBG1 AP3D1 U2SURP CEP192 ARHGAP35 POLR3B SIPA1L1 MARK2 SRRM2 PALLD CEP170B | 1.04e-06 | 464 | 244 | 20 | int:GSK3A |
| Interaction | CBX3 interactions | BRPF3 INCENP ZMYND8 CHD1 TRIP12 CIC DNTTIP2 BLM BBX GLYR1 MKI67 KDM2B FGD5 NIPBL PHIP RBBP6 COBLL1 ZNF280C NUMA1 ESF1 MDC1 SMARCA4 SRRM2 TP53BP1 | 1.21e-06 | 646 | 244 | 24 | int:CBX3 |
| Interaction | ACTC1 interactions | WIPF3 ZNF318 CIC LUZP1 TLK1 DDX46 MKI67 FGD5 DYNC1H1 RBBP6 COBLL1 U2SURP NUMA1 DNM1L ARHGAP35 ATP8B2 LARP7 ESF1 ZZZ3 MDC1 SMARCA4 SRRM2 TP53BP1 LRRFIP2 SON | 1.25e-06 | 694 | 244 | 25 | int:ACTC1 |
| Interaction | HDAC4 interactions | DTD1 DENND4A ABI3 LSG1 PACSIN3 DDX46 PI4KA NAV3 PHIP AP3D1 EXOSC10 SAE1 SRGAP2 RFX5 LARP7 KIF3A NCOR2 MAP1S EGR2 SH3PXD2A SIPA1L1 ANKRD11 DYNC1LI1 MARK2 TP53BP1 LRRFIP2 | 1.33e-06 | 744 | 244 | 26 | int:HDAC4 |
| Interaction | EZH1 interactions | 1.75e-06 | 92 | 244 | 9 | int:EZH1 | |
| Interaction | GLDC interactions | PPP2R2D SIPA1L3 ZC3H3 LUZP1 SAFB SVIL TJP2 JCAD CDC42BPA RBBP6 MYO18A LARP7 ESF1 SIPA1L1 SMARCA4 MARK2 | 2.05e-06 | 321 | 244 | 16 | int:GLDC |
| Interaction | MECP2 interactions | MAP1B MYCBP2 VWA8 MARK1 LSG1 ZMYND8 HMGN1 GPATCH8 TRIP12 BLM ZMAT5 SAFB DDX46 BBX GLYR1 MKI67 NIPBL AP3D1 DYNC1H1 DYNC1LI2 NPAS2 RBM15 EXOSC10 CDC42BPA SRSF5 RBBP6 POLDIP3 U2SURP MYO18A ARHGAP35 ESF1 SMARCA4 DYNC1LI1 SRRM2 TP53BP1 SON | 2.25e-06 | 1287 | 244 | 36 | int:MECP2 |
| Interaction | SIRT6 interactions | MYCBP2 LSG1 SRPK2 ZNF318 GPATCH8 TRIP12 DNTTIP2 BLM FAT1 MKI67 FAT4 EXOSC10 FAT3 NUMA1 ZFC3H1 LARP7 ESF1 MDC1 SMARCA4 MPHOSPH10 USP54 PALLD TP53BP1 | 2.59e-06 | 628 | 244 | 23 | int:SIRT6 |
| Interaction | RCOR1 interactions | MYCBP2 ZMYND8 ZNF318 CIC LUZP1 DDX46 BRCA2 MKI67 KDM2B PHIP NPAT CASP8AP2 PHF12 NUMA1 PALB2 NCOR2 ZZZ3 SMARCA4 TP53BP1 EXOC4 | 2.72e-06 | 494 | 244 | 20 | int:RCOR1 |
| Interaction | FBXO22 interactions | ZMYND8 GPRIN1 TRIP12 BLM KMT2C DDX46 NAV2 TJP2 AP3D1 RBM15 ANK3 DOCK9 U2SURP NUMA1 TOGARAM2 NCOR2 ZNF106 MAP1S ANKRD11 MARK2 TP53BP1 | 2.86e-06 | 540 | 244 | 21 | int:FBXO22 |
| Interaction | DHX8 interactions | SRPK2 CHD1 ZNF318 GPATCH8 BLM SAFB DDX46 RBM15 RBBP6 POLDIP3 U2SURP ZFC3H1 SCAF11 SRRM2 SON | 2.98e-06 | 292 | 244 | 15 | int:DHX8 |
| Interaction | UQCR11 interactions | 3.36e-06 | 53 | 244 | 7 | int:UQCR11 | |
| Interaction | H2AJ interactions | GON4L TRIP12 DNTTIP2 DDX46 TJP2 CRAMP1 NPAT RBBP6 LARP7 ESF1 | 3.41e-06 | 127 | 244 | 10 | int:H2AJ |
| Interaction | HSD17B7P2 interactions | 4.34e-06 | 21 | 244 | 5 | int:HSD17B7P2 | |
| Interaction | CALD1 interactions | SIPA1L3 TRIP12 LUZP1 SVIL TJP2 LMOD1 FGD5 DYNC1LI2 MYO18A SRGAP2 ANKRD11 LRP1 DYNC1LI1 MPHOSPH10 | 4.63e-06 | 265 | 244 | 14 | int:CALD1 |
| Interaction | DISC1 interactions | TSPOAP1 LSG1 ZNF318 LUZP1 KIF9 GLYR1 SVIL TJP2 KIF3C DYNC1H1 FNDC3B FRYL SRGAP2 LARP7 KIF3A USP54 TNKS2 EXOC4 | 5.33e-06 | 429 | 244 | 18 | int:DISC1 |
| Interaction | USP53 interactions | TRIP12 DNTTIP2 DDX46 MKI67 TJP2 AP3D1 DYNC1H1 EXOSC10 COPB1 U2SURP | 7.18e-06 | 138 | 244 | 10 | int:USP53 |
| Interaction | CEBPA interactions | MYCBP2 INPP5D ZMYND8 HMGN1 CHD1 ZNF318 CIC KMT2C TLK1 SAFB MKI67 BIN2 USF1 C2orf49 NIPBL DYNC1H1 NCAPD3 RBM15 EXOSC10 SRSF5 POLDIP3 PHF12 U2SURP TOGARAM2 SAE1 RFX5 TFAP4 PALB2 NCOR2 SMARCA4 DYNC1LI1 BICRAL SRRM2 TP53BP1 | 7.45e-06 | 1245 | 244 | 34 | int:CEBPA |
| Interaction | CDC14A interactions | 8.34e-06 | 111 | 244 | 9 | int:CDC14A | |
| Interaction | PARP1 interactions | ABL1 VRK3 INCENP MYCBP2 HMGN1 CHD1 TRIP12 CIC DNTTIP2 KRT80 BLM BBX BRCA2 GLYR1 SVIL MKI67 KDM2B USF1 NIPBL PHIP AP3D1 FNDC3B MTF2 U2SURP NUMA1 DNM1L RFX5 LARP7 ESF1 ZNF106 SMARCA4 SCAF11 MPHOSPH10 MARK2 TP53BP1 | 9.55e-06 | 1316 | 244 | 35 | int:PARP1 |
| Interaction | ZBTB2 interactions | BRPF3 INCENP TMC6 ZMYND8 SRPK2 CHD1 SAFB GLYR1 PHIP SRSF5 COPB1 MTF2 ZNF280C NUMA1 LARP7 MDC1 TP53BP1 SON | 1.02e-05 | 450 | 244 | 18 | int:ZBTB2 |
| Interaction | TJP2 interactions | INPP5D SIPA1L3 SRPK2 LUZP1 SAFB SVIL TJP2 FGD5 JCAD MYO18A ARHGAP35 SIPA1L1 USP54 SRRM2 | 1.20e-05 | 288 | 244 | 14 | int:TJP2 |
| Interaction | TRRAP interactions | FOXR1 VWA8 DNTTIP2 FBXO38 BRCA2 PI4KA GLYR1 MKI67 FGD5 USF1 CNOT3 DYNC1H1 NPAT JCAD CASP8AP2 RBM15 FAT4 MYO18A ARHGEF15 NCOR2 ZZZ3 MDC1 SMARCA4 MPHOSPH10 LRRFIP2 | 1.21e-05 | 790 | 244 | 25 | int:TRRAP |
| Interaction | TOPBP1 interactions | 1.28e-05 | 117 | 244 | 9 | int:TOPBP1 | |
| Interaction | NINL interactions | MYO5A SIPA1L3 LUZP1 BRCA2 MTUS1 SVIL ANAPC2 CNOT3 DYNC1H1 DYNC1LI2 NCAPD3 CEP192 ZFC3H1 SIPA1L1 DYNC1LI1 USP54 PALLD CEP170B | 1.30e-05 | 458 | 244 | 18 | int:NINL |
| Interaction | KCTD13 interactions | GPRASP1 MAP1B MYO5A MARK1 SIPA1L3 SRPK2 LUZP1 USP31 PI4KA SVIL SORCS2 TJP2 AP3D1 DYNC1H1 SGIP1 SRSF5 ANK3 NRCAM COPB1 PRR36 NCKIPSD MYO18A TPPP DNM1L SRGAP2 ARHGAP35 KIF3A MAP1S SIPA1L1 SMARCA4 USP54 MARK2 PCDH1 CEP170B LRRFIP2 EXOC4 | 1.33e-05 | 1394 | 244 | 36 | int:KCTD13 |
| Interaction | MKI67 interactions | MAP1B SRPK2 DNTTIP2 BBX BRCA2 PI4KA MKI67 NAV2 NIPBL TICRR SRSF5 TEDC2 SMARCAL1 NUMA1 ZNF106 POLR3B SIPA1L1 MDC1 SCAF11 MPHOSPH10 MARK2 SON | 1.42e-05 | 648 | 244 | 22 | int:MKI67 |
| Interaction | TLE3 interactions | ZNF318 GPATCH8 EYA2 CIC SVEP1 BRCA2 MCM3AP NIPBL ANK3 COPB1 RBBP6 NCOR2 EGR2 SMARCA4 SRRM2 SON | 1.51e-05 | 376 | 244 | 16 | int:TLE3 |
| Interaction | CDC5L interactions | SRPK2 CIC DDX46 ANAPC2 KIF3C OXSR1 NIPBL DYNC1H1 DYNC1LI2 EXOSC10 SRSF5 COPB1 RBBP6 SMARCAL1 U2SURP DNM1L NIBAN2 LARP7 MDC1 SMARCA4 DYNC1LI1 BICRAL MARK2 SRRM2 SON EXOC4 | 1.60e-05 | 855 | 244 | 26 | int:CDC5L |
| Interaction | HMGN5 interactions | INCENP TRIP12 GLYR1 NIPBL PHIP MTF2 ZNF280C NUMA1 MDC1 SCAF11 | 1.88e-05 | 154 | 244 | 10 | int:HMGN5 |
| Interaction | CAPZA2 interactions | MYO5A UBE4B SIPA1L3 PACSIN3 LUZP1 SVIL AMOTL1 CRYBG1 CNOT3 RBBP6 NCKIPSD NUMA1 MYO18A ZNF106 DYNC1LI1 MARK2 LRRFIP2 | 2.10e-05 | 430 | 244 | 17 | int:CAPZA2 |
| Interaction | DDX23 interactions | MAP1B SRPK2 CHD1 GPATCH8 DNTTIP2 SAFB DDX46 TJP2 RBM15 RBBP6 POLDIP3 U2SURP LARP7 ESF1 ANKRD11 SCAF11 MPHOSPH10 SRRM2 | 2.42e-05 | 480 | 244 | 18 | int:DDX23 |
| Interaction | APEX1 interactions | GPRASP1 INCENP MYO5A ZMYND8 SRPK2 HMGN1 TRIP12 DNTTIP2 CREBZF BLM SAFB BBX BRCA2 GLYR1 NIPBL CNOT3 BRWD1 SRSF5 POLDIP3 TEDC2 DOCK9 SMARCAL1 ZNF280C R3HCC1 NUMA1 DNM1L RFX5 TFAP4 ANKRD11 SMARCA4 SCAF11 MARK2 TP53BP1 | 2.86e-05 | 1271 | 244 | 33 | int:APEX1 |
| Interaction | TRIM37 interactions | MYO5A SIPA1L3 ZNF318 KIF9 MCM3AP SVIL MKI67 COPB1 RBBP6 U2SURP MYO18A CEP192 RFX5 NCOR2 C2CD3 SIPA1L1 ANKRD11 LRP1 PALLD CEP170B LRRFIP2 | 2.93e-05 | 630 | 244 | 21 | int:TRIM37 |
| Interaction | CIT interactions | GPRASP1 INCENP VWA8 ZMYND8 ASH1L HMGN1 CHD1 TRIP12 DNTTIP2 LUZP1 SAFB DDX46 GLYR1 SVIL MKI67 TJP2 OXSR1 NIPBL PHIP DYNC1H1 RBM15 EXOSC10 SRSF5 COPB1 RBBP6 POLDIP3 NCKIPSD NUMA1 MYO18A ESF1 MDC1 SMARCA4 SCAF11 MPHOSPH10 SRRM2 SON | 3.09e-05 | 1450 | 244 | 36 | int:CIT |
| Interaction | NUPR1 interactions | MYO5A SIPA1L3 PACSIN3 TRIP12 DNTTIP2 LUZP1 KRT80 SAFB DDX46 PI4KA SVIL MKI67 RBM15 SRSF5 POLDIP3 U2SURP NUMA1 MYO18A ZDHHC5 SRGAP2 MDC1 SRRM2 | 3.16e-05 | 683 | 244 | 22 | int:NUPR1 |
| Interaction | HMBOX1 interactions | 3.16e-05 | 131 | 244 | 9 | int:HMBOX1 | |
| Interaction | NIN interactions | SIPA1L3 LUZP1 BRCA2 SVIL AP3D1 DYNC1H1 DYNC1LI2 CEP192 C2CD3 SIPA1L1 DYNC1LI1 USP54 PALLD CEP170B EXOC4 | 3.45e-05 | 359 | 244 | 15 | int:NIN |
| Interaction | BRD3 interactions | ZMYND8 SRPK2 HMGN1 CHD1 TRIP12 DNTTIP2 BBX MKI67 NIPBL PHIP RBBP6 NUMA1 LARP7 POLR3B MDC1 SMARCA4 SRRM2 SON | 3.53e-05 | 494 | 244 | 18 | int:BRD3 |
| Interaction | DYNLT1 interactions | SYNRG ZNF318 LUZP1 BLM MTUS1 SVIL DYNC1H1 DYNC1LI2 BRWD1 PHF12 DYNC1LI1 EXOC4 | 4.00e-05 | 241 | 244 | 12 | int:DYNLT1 |
| Interaction | DYRK1A interactions | MAP1B MYCBP2 SIPA1L3 SRPK2 TRIP12 CIC MAP3K1 LUZP1 ANAPC2 MKI67 TJP2 CNOT3 JCAD SRSF5 NCOR2 SIPA1L1 USP54 PALLD LRRFIP2 | 4.62e-05 | 552 | 244 | 19 | int:DYRK1A |
| Interaction | IFI6 interactions | 4.70e-05 | 54 | 244 | 6 | int:IFI6 | |
| Interaction | H2AC4 interactions | ZMYND8 GON4L HMGN1 TRIP12 BLM KMT2C GLYR1 SVIL UNC79 COPB1 POLDIP3 NUMA1 DNM1L LARP7 DYNC1LI1 SCAF11 TP53BP1 EXOC4 | 4.82e-05 | 506 | 244 | 18 | int:H2AC4 |
| Interaction | MDC1 interactions | SRPK2 TRIP12 BRCA2 ANAPC2 MKI67 FGF12 C2orf49 PHF12 U2SURP NUMA1 TFAP4 ZNF106 MDC1 SMARCA4 TNKS2 TP53BP1 | 4.83e-05 | 414 | 244 | 16 | int:MDC1 |
| Interaction | ASF1A interactions | INCENP BLM FBXO38 TLK1 BRCA2 NPAT CASP8AP2 COPB1 NUMA1 NCOR2 MDC1 SMARCA4 | 5.48e-05 | 249 | 244 | 12 | int:ASF1A |
| Interaction | HMGA1 interactions | VRK3 INPP5D SRPK2 CHD1 FBXO38 BRCA2 UNC79 PHIP CNOT3 MTF2 ZNF280C NUMA1 NCOR2 MDC1 SMARCA4 SCAF11 | 5.57e-05 | 419 | 244 | 16 | int:HMGA1 |
| Interaction | PSENEN interactions | 5.68e-05 | 81 | 244 | 7 | int:PSENEN | |
| Interaction | AFDN interactions | SIPA1L3 AMOTL1 TJP2 JCAD CDC42BPA TEDC2 ZDHHC5 SRGAP2 CEP192 NIBAN2 SH3PXD2A SIPA1L1 USP54 MARK2 | 5.90e-05 | 333 | 244 | 14 | int:AFDN |
| Interaction | PPP1CB interactions | VRK3 MYO5A MYCBP2 SIPA1L3 PPP1R15A LUZP1 TLK1 SAFB SVIL FGD5 DYNC1H1 NUMA1 MYO18A ZDHHC5 LARP7 ZNF106 DYNC1LI1 | 6.22e-05 | 469 | 244 | 17 | int:PPP1CB |
| Interaction | NUMA1 interactions | UBE4B TRIP12 BRAP GLYR1 ZFYVE21 MKI67 PHIP DYNC1H1 MTF2 TEDC2 ZNF280C R3HCC1 NUMA1 MDC1 SMARCA4 DYNC1LI1 TP53BP1 | 6.22e-05 | 469 | 244 | 17 | int:NUMA1 |
| Interaction | FBXO38 interactions | 7.01e-05 | 145 | 244 | 9 | int:FBXO38 | |
| Interaction | DDX39B interactions | C19orf47 SRPK2 HMGN1 LUZP1 KRT80 SVIL C2orf49 DYNC1H1 DYNC1LI2 RBM15 POLDIP3 MYO18A DNM1L ZFC3H1 TFAP4 MDC1 SRRM2 TP53BP1 LRRFIP2 | 7.08e-05 | 570 | 244 | 19 | int:DDX39B |
| Interaction | BRCA2 interactions | ABL1 GPR179 BRCA2 ANAPC2 MKI67 NIPBL DYNC1H1 DYNC1LI2 POLDIP3 SMARCAL1 SAE1 PALB2 MDC1 DYNC1LI1 TP53BP1 | 7.40e-05 | 384 | 244 | 15 | int:BRCA2 |
| Interaction | MEX3A interactions | ABL1 EML6 ZMYND8 FAT1 GLYR1 SVIL AMOTL1 CNOT3 DYNC1H1 R3HCC1 NUMA1 SAE1 ANKRD11 SMARCA4 SON | 7.40e-05 | 384 | 244 | 15 | int:MEX3A |
| Interaction | FGFBP1 interactions | ASH1L SRPK2 TRIP12 BBX GLYR1 MKI67 RBM15 SRSF5 ZFC3H1 LARP7 ESF1 MPHOSPH10 | 7.42e-05 | 257 | 244 | 12 | int:FGFBP1 |
| Interaction | CLK1 interactions | DENND4A SRPK2 FAT1 SAFB TJP2 RBM15 SRSF5 RBBP6 PPFIBP2 DOCK9 SRRM2 | 7.75e-05 | 219 | 244 | 11 | int:CLK1 |
| Interaction | DSCR9 interactions | 7.79e-05 | 147 | 244 | 9 | int:DSCR9 | |
| Interaction | KIF20A interactions | BRPF3 INCENP VWA8 EML6 PACSIN3 HMGN1 CHD1 ZNF318 CDK14 LUZP1 BLM SAFB DDX46 SVIL MKI67 NAV3 NAV2 TJP2 SRSF5 RBBP6 NUMA1 MYO18A ZNF106 MDC1 SMARCA4 USP54 SRRM2 SON | 7.96e-05 | 1052 | 244 | 28 | int:KIF20A |
| Interaction | PPIA interactions | ABL1 MAP1B INCENP ZMYND8 SRPK2 CHD1 CIC BLM SAFB DDX46 BBX MKI67 CNOT3 DYNC1LI2 ANK3 POLDIP3 U2SURP ZNF280C DNM1L ARHGAP35 DYNC1LI1 ANKRD36 MPHOSPH10 SRRM2 TP53BP1 | 8.18e-05 | 888 | 244 | 25 | int:PPIA |
| Interaction | MYO18A interactions | MYO5A SIPA1L3 LUZP1 DDX46 SVIL TJP2 FGD5 CDC42BPA SRSF5 U2SURP MYO18A SMARCA4 LRRFIP2 | 8.83e-05 | 303 | 244 | 13 | int:MYO18A |
| Interaction | DYNLL2 interactions | MYO5A FBXO38 KMT2C TLK1 AMOTL1 DYNC1H1 DYNC1LI2 JCAD TPPP DYNC1LI1 CEP170B TP53BP1 | 9.24e-05 | 263 | 244 | 12 | int:DYNLL2 |
| Interaction | PPP1CC interactions | MYCBP2 KIF26A MARK1 HMGN1 ZNF318 PPP1R15A CIC MTUS1 SVIL AMOTL1 MKI67 RBM15 SRSF5 PHF12 NUMA1 ZFC3H1 LARP7 POLR3B SNCAIP SRRM2 LRRFIP2 SON | 9.87e-05 | 738 | 244 | 22 | int:PPP1CC |
| Interaction | EGLN3 interactions | DENND4A MYCBP2 VWA8 LSG1 SIPA1L3 CHD1 ZNF318 GPATCH8 CDK14 BRAP BLM BRCA2 MAGED4 PI4KA PIPSL AP3D1 CNOT3 DYNC1H1 JCAD TICRR NCAPD3 COPB1 SAE1 CEP192 NPLOC4 NCOR2 ZNF106 ANKRD11 DYNC1LI1 USP54 CEP170B EXOC4 | 9.88e-05 | 1296 | 244 | 32 | int:EGLN3 |
| Interaction | SYNGAP1 interactions | GPRASP1 MAP1B MYO5A MYCBP2 GPRIN1 PI4KA DYNC1H1 NYAP2 SGIP1 DNM1L SRGAP2 SIPA1L1 TP53BP1 | 1.01e-04 | 307 | 244 | 13 | int:SYNGAP1 |
| Interaction | RPSA2 interactions | 1.01e-04 | 152 | 244 | 9 | int:RPSA2 | |
| Interaction | USP11 interactions | BRPF3 MYCBP2 TRIP12 CIC FBXO38 BRCA2 MKI67 DYNC1H1 EXOSC10 SRSF5 POLDIP3 NUMA1 MYO18A PHF7 PALB2 CD4 SIPA1L1 LRRFIP2 | 1.07e-04 | 539 | 244 | 18 | int:USP11 |
| GeneFamily | PHD finger proteins | 8.18e-08 | 90 | 156 | 9 | 88 | |
| GeneFamily | Dyneins, cytoplasmic | 1.69e-04 | 13 | 156 | 3 | 538 | |
| GeneFamily | Cadherin related | 3.92e-04 | 17 | 156 | 3 | 24 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.56e-04 | 46 | 156 | 4 | 622 | |
| GeneFamily | PWWP domain containing | 8.60e-04 | 22 | 156 | 3 | 1147 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.12e-03 | 53 | 156 | 4 | 532 | |
| GeneFamily | Transcription elongation factor A like family | 2.56e-03 | 9 | 156 | 2 | 1216 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.10e-03 | 34 | 156 | 3 | 487 | |
| GeneFamily | Zinc fingers CCCH-type | 3.37e-03 | 35 | 156 | 3 | 73 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ABL1 ZMYND8 CHD1 ZNF318 TLK1 FAT1 BBX MTUS1 MKI67 NAV3 PHIP NPAS2 NPAT DOCK9 FRYL ZFC3H1 LARP7 ZZZ3 MDC1 SCAF11 BICRAL MPHOSPH10 | 1.33e-13 | 300 | 247 | 22 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAP1B MYCBP2 ZMYND8 SRPK2 CHD1 ATP8B1 GPATCH8 TRIP12 BLM TLK1 FAT1 DLC1 BBX BRCA2 NAV3 TJP2 OXSR1 NIPBL PHIP NPAT CDC42BPA MTF2 DOCK9 U2SURP FRYL SRGAP2 ARHGAP35 NCOR2 C2CD3 ZZZ3 SIPA1L1 BICRAL TP53BP1 SON | 1.50e-12 | 856 | 247 | 34 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SYNRG DENND4A ABI3 MYO5A MYCBP2 INPP5D TMC6 ASH1L HMGN1 CHD1 GPATCH8 PPP1R15A KMT2E TRIP12 DNTTIP2 LUZP1 KMT2C TLK1 BBX CRYBG1 PLCB2 BIN2 NIPBL PHIP DYNC1H1 BRWD1 NPAT SRSF5 COPB1 RBBP6 DOCK9 U2SURP NUMA1 TSEN54 FRYL ZFC3H1 ARHGAP35 RFX5 ATP8B2 CD4 ANKRD11 PCNX1 SCAF11 SON | 1.41e-11 | 1492 | 247 | 44 | M40023 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | ABL1 ZMYND8 TLK1 FAT1 BBX MTUS1 MKI67 NAV3 PHIP NPAS2 DOCK9 FRYL LARP7 ZZZ3 | 1.10e-10 | 145 | 247 | 14 | M1810 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAP1B MYCBP2 ZMYND8 SRPK2 CHD1 TRIP12 BLM TLK1 FAT1 DLC1 BBX TJP2 OXSR1 PHIP CDC42BPA MTF2 U2SURP FRYL SRGAP2 C2CD3 ZZZ3 | 4.04e-09 | 466 | 247 | 21 | M13522 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | GPRASP1 INPP5D GON4L CHD1 ZNF318 PPP1R15A MAP3K1 LUZP1 CREBZF HELB BBX C2orf49 DYNC1LI2 SRSF5 ANK3 RBBP6 DOCK9 AFF3 NUMA1 TNKS2 | 2.87e-08 | 474 | 247 | 20 | M40991 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPRASP1 MAP1B MYO5A MYCBP2 TSPOAP1 MARK1 ZMYND8 LRRC2 ZNF318 KMT2E FSIP2 MTUS1 NAV3 KDM2B FGF12 KIF3C UNC79 BRWD1 ANK3 AFF3 ARHGAP35 KIF3A ANKRD36B SH3PXD2A TNFSF13B ZFHX2 ROBO2 ANKRD36 PAX5 PCDH1 | 2.16e-07 | 1106 | 247 | 30 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TCEAL3 MYO5A MYCBP2 CHD1 BLM DDX46 BBX MTUS1 MKI67 NIPBL CASP8AP2 CDC42BPA DNM1L CEP192 LARP7 ESF1 KIF3A ZZZ3 SCAF11 MPHOSPH10 PALLD SON | 3.16e-07 | 656 | 247 | 22 | M18979 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | BRPF3 NAV2 AP3D1 DYNC1LI2 SGIP1 CDC42BPA MTF2 SRGAP2 C2CD3 SH3PXD2A SON | 5.43e-07 | 166 | 247 | 11 | M6826 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | GPRASP1 MAP1B MYO5A MYCBP2 MARK1 EML6 ASH1L ZNF318 KMT2C BBX PI4KA NAV2 UNC79 DYNC1H1 CDC42BPA NRCAM COBLL1 U2SURP GLIS3 ARHGAP35 KIF3A NCOR2 ZNF106 ZZZ3 ROBO2 TNKS2 | 1.16e-06 | 946 | 247 | 26 | M39169 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | ABL1 INCENP TLK1 BRCA2 KIF3C DYNC1H1 CDC42BPA NUMA1 CEP192 MAP1S PALLD | 3.22e-06 | 199 | 247 | 11 | M5893 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GPRASP1 MAP1B TSPOAP1 MARK1 CDK14 NAV3 KIF3C UNC79 FAT4 ANK3 FAT3 TPPP PALB2 KIF3A ANKRD36B ZFHX2 ROBO2 BICRAL PCDH1 | 3.22e-06 | 584 | 247 | 19 | M39068 |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | ABL1 GPATCH8 GLYR1 AP3D1 ESF1 C2CD3 SMARCA4 SCAF11 MARK2 SON | 5.23e-06 | 170 | 247 | 10 | M5657 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ABI3 MARK1 ATXN7L1 ASH1L WIPF3 ATP8B1 CREBZF KMT2C BBX MTUS1 AMOTL1 FGD5 DYNC1LI2 JCAD FNDC3B SGIP1 RBBP6 MYO18A FRYL ARHGEF15 SNCAIP PALLD SON | 6.91e-06 | 854 | 247 | 23 | M1533 |
| Coexpression | BURTON_ADIPOGENESIS_12 | 1.17e-05 | 32 | 247 | 5 | M1558 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ABI3 MARK1 ATXN7L1 ASH1L WIPF3 ATP8B1 CREBZF KMT2C BBX MTUS1 AMOTL1 FGD5 DYNC1LI2 JCAD FNDC3B SGIP1 RBBP6 MYO18A FRYL ARHGEF15 SNCAIP PALLD SON | 1.29e-05 | 888 | 247 | 23 | MM1018 |
| Coexpression | GABRIELY_MIR21_TARGETS | MYCBP2 SRPK2 MAP3K1 DDX46 CRYBG1 NIPBL PHIP DYNC1LI2 COBLL1 POLR3B SCAF11 PALLD | 2.12e-05 | 289 | 247 | 12 | M2196 |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 2.16e-05 | 200 | 247 | 10 | M9354 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | GPRASP1 TRIP12 CREBZF FBXO38 MCM3AP SVIL ANAPC2 CRYBG1 ANKRD36 TNKS2 | 2.16e-05 | 200 | 247 | 10 | M9889 |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN | ABL1 SIPA1L3 KIF9 ZFYVE21 MKI67 KDM2B DYNC1LI2 NCKIPSD MYO18A SRGAP2 | 2.16e-05 | 200 | 247 | 10 | M7196 |
| Coexpression | GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN | VRK3 KMT2E TJP2 KDM2B KIF3C JCAD ZNF280C ARHGAP35 ATP8B2 TNKS2 | 2.16e-05 | 200 | 247 | 10 | M7791 |
| Coexpression | GSE37301_PRO_BCELL_VS_CD4_TCELL_DN | 2.83e-05 | 165 | 247 | 9 | M8907 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | PPP2R2D UBE4B SNX19 LUZP1 CREBZF AMOTL1 MKI67 FGD5 OXSR1 NPAT NCAPD3 EXOSC10 NUMA1 FRYL CUTC C2CD3 SH3PXD2A GPR153 DYNC1LI1 ZC3H12C TNKS2 | 2.91e-05 | 807 | 247 | 21 | M14594 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | VRK3 MCM8 INCENP ZC3H3 MAP3K1 BRAP BLM BRCA2 PI4KA MKI67 NPAT CASP8AP2 NCAPD3 RBM15 NCKIPSD PHF7 SRGAP2 CEP192 ANKRD36B NCOR2 CD4 SMARCA4 ANKRD36 | 3.10e-05 | 939 | 247 | 23 | M45768 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | WIPF3 LRRC2 FAT1 FNDC3B SGIP1 SRGAP2 ANKRD11 ROBO2 ANKRD36 PALLD | 3.56e-05 | 212 | 247 | 10 | M39221 |
| Coexpression | KOYAMA_SEMA3B_TARGETS_DN | ASH1L GON4L SRPK2 LNP1 SVIL ODAD3 TICRR C10orf67 PHF7 RFX5 LARP7 GPR153 EXOC4 | 4.63e-05 | 364 | 247 | 13 | M2029 |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 4.91e-05 | 101 | 247 | 7 | M15356 | |
| Coexpression | FISCHER_DREAM_TARGETS | MCM8 INCENP CREBZF BLM DDX46 BRCA2 MKI67 CRYBG1 NIPBL NPAT CASP8AP2 TICRR NCAPD3 MTF2 RBBP6 TEDC2 SAE1 CEP192 TFAP4 PALB2 LARP7 MDC1 EXOC4 | 5.01e-05 | 969 | 247 | 23 | M149 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ABL1 MCM8 GON4L PPP1R15A ZC3H3 CREBZF PI4KA MCM3AP PLCB2 AP3D1 EXOSC10 VASH1 TOGARAM2 MYO18A CEP192 NIBAN2 ANKRD36B MDC1 ANKRD11 SMARCA4 ANKRD36 SRRM2 | 5.18e-05 | 905 | 247 | 22 | M40865 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MCM8 DNTTIP2 KRT80 BRAP USP31 FBXO38 KMT2C TLK1 BRCA2 NIPBL PHIP AP3D1 BRWD1 RBBP6 U2SURP DNM1L SRGAP2 ESF1 MPHOSPH10 | 5.96e-05 | 721 | 247 | 19 | M10237 |
| Coexpression | WHITFIELD_CELL_CYCLE_S | 9.24e-05 | 150 | 247 | 8 | M2075 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | MYCBP2 ZMYND8 ASH1L CDK14 NKX2-8 RBBP6 COBLL1 SCAF11 ZC3H12C | 9.55e-05 | 193 | 247 | 9 | M6813 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | GPRASP1 MAP1B MYO5A NAV3 UNC79 ANK3 FAT3 TPPP KIF3A ANKRD36B SH3PXD2A ZFHX2 ROBO2 BICRAL PCDH1 | 1.01e-04 | 506 | 247 | 15 | M39067 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | ATP8B1 EYA2 CREBZF BRWD1 CASP8AP2 CDC42BPA MTF2 U2SURP ANKRD36B | 1.03e-04 | 195 | 247 | 9 | M13736 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | MYCBP2 ZMYND8 ASH1L CDK14 NKX2-8 RBBP6 COBLL1 SCAF11 ZC3H12C | 1.07e-04 | 196 | 247 | 9 | MM667 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | SLCO2B1 INPP5D TMC6 ATP8B1 MAP3K1 LUZP1 MTUS1 SVIL AMOTL1 FGD5 NPAS2 JCAD DOCK9 COBLL1 VASH1 TMEM255B ARHGEF15 CD4 EGR2 SH3PXD2A USP54 | 1.13e-04 | 888 | 247 | 21 | M39049 |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | MYCBP2 SIPA1L3 MAP3K1 BIN2 SRSF5 PPFIBP2 ZFC3H1 ZFHX2 BICRAL | 1.20e-04 | 199 | 247 | 9 | M4526 |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP | 1.20e-04 | 199 | 247 | 9 | M5270 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 1.20e-04 | 199 | 247 | 9 | M9253 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 1.20e-04 | 199 | 247 | 9 | M5607 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | 1.25e-04 | 200 | 247 | 9 | M3365 | |
| Coexpression | GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP | 1.25e-04 | 200 | 247 | 9 | M8514 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.25e-04 | 200 | 247 | 9 | M4456 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZMYND8 GON4L CHD1 CDK14 KMT2C TLK1 TJP2 FAT4 POLDIP3 AFF3 FRYL LRP1 PALLD CEP170B | 1.53e-04 | 467 | 247 | 14 | M1347 |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.56e-04 | 206 | 247 | 9 | M39254 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | CHD1 SLC35D1 GLYR1 MCM3AP COPB1 MTF2 PPFIBP2 R3HCC1 NUMA1 C2CD3 | 1.93e-04 | 260 | 247 | 10 | M41075 |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.94e-04 | 212 | 247 | 9 | MM3816 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 2.02e-04 | 168 | 247 | 8 | M18811 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.10e-04 | 169 | 247 | 8 | M39230 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZMYND8 GON4L CHD1 CDK14 KMT2C TLK1 TJP2 FAT4 POLDIP3 AFF3 FRYL LRP1 PALLD CEP170B | 2.21e-04 | 484 | 247 | 14 | MM999 |
| Coexpression | BURTON_ADIPOGENESIS_12 | 2.25e-04 | 32 | 247 | 4 | MM668 | |
| Coexpression | KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN | 2.54e-04 | 33 | 247 | 4 | M2106 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 2.57e-04 | 174 | 247 | 8 | M6850 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 2.67e-04 | 175 | 247 | 8 | M6723 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | MYCBP2 ZMYND8 SRPK2 LUZP1 NPAS2 CDC42BPA ZDHHC5 FRYL SRRM2 SON | 2.76e-04 | 272 | 247 | 10 | M15123 |
| Coexpression | VANTVEER_BREAST_CANCER_BRCA1_UP | 2.86e-04 | 34 | 247 | 4 | M16737 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 2.88e-04 | 177 | 247 | 8 | M9401 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | MCM8 INPP5D KRT80 FAT1 DLC1 PI4KA SVIL NAV2 DYNC1H1 SRSF5 ATOH8 PALLD | 2.96e-04 | 382 | 247 | 12 | M38972 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | ASH1L CHD1 PPP1R15A C2orf49 RBM15 RBBP6 SRGAP2 ZFC3H1 EGR2 SCAF11 | 3.10e-04 | 276 | 247 | 10 | M41128 |
| Coexpression | GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN | 3.11e-04 | 179 | 247 | 8 | M8928 | |
| Coexpression | GENTILE_UV_LOW_DOSE_DN | 3.46e-04 | 64 | 247 | 5 | M4594 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | MAP1B MYO5A KIF26A GPRIN1 FGF12 KIF3C UNC79 ANK3 KIF3A ROBO2 BICRAL | 3.64e-04 | 335 | 247 | 11 | M39065 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | POU6F2 MCM8 MAP1B INCENP EML6 CHD1 DNTTIP2 LUZP1 SAFB DDX46 BBX BRCA2 FGF12 NIPBL PHIP CASP8AP2 CEP192 PALB2 LARP7 ESF1 ZNF106 ANKRD11 SCAF11 ZC3H12C MPHOSPH10 | 2.22e-09 | 532 | 241 | 25 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | MCM8 INCENP EML6 CHD1 PPP1R15A DNTTIP2 LUZP1 DDX46 BBX BRCA2 NIPBL PHIP EXOSC10 CEP192 ESF1 MDC1 ANKRD11 SCAF11 MPHOSPH10 TNKS2 | 4.55e-07 | 469 | 241 | 20 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG DENND4A TCEAL3 MAP1B INCENP VWA8 PACSIN3 EVC CHD1 KMT2E DNTTIP2 SAFB DDX46 MTUS1 ZFYVE21 FGF12 PHIP CASP8AP2 FAT4 CDC42BPA RBBP6 FAT3 ZC3H12C MPHOSPH10 | 4.82e-07 | 654 | 241 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | POU6F2 MAP1B MYO5A CHD1 LUZP1 BLM NKX2-8 SAFB DDX46 BRCA2 MKI67 NAV2 FGF12 NIPBL PHIP BRWD1 CASP8AP2 NRCAM PRR36 RBBP6 FAT3 U2SURP FRYL ESF1 KIF3A SMARCA4 ZFHX2 ZC3H12C MPHOSPH10 LRRFIP2 | 9.65e-07 | 989 | 241 | 30 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAP1B MYO5A ASH1L GON4L SRPK2 CHD1 LUZP1 BRAP SAFB DDX46 BRCA2 MKI67 FGF12 C2orf49 NIPBL PHIP CASP8AP2 RBBP6 FAT3 NUMA1 ESF1 KIF3A ROBO2 ZC3H12C MPHOSPH10 LRRFIP2 EXOC4 | 9.67e-07 | 831 | 241 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MYO5A LUZP1 BLM SAFB DDX46 BRCA2 MKI67 NIPBL PHIP CASP8AP2 RBBP6 ESF1 KIF3A MPHOSPH10 LRRFIP2 | 2.95e-06 | 311 | 241 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | POU6F2 MAP1B CHD1 LUZP1 DDX46 BRCA2 FGF12 ESF1 ZNF106 SCAF11 ZC3H12C MPHOSPH10 | 3.97e-06 | 204 | 241 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | DTD1 ABI3 ZMYND8 CREBZF SLC35D1 BLM GLYR1 NAV2 OXSR1 USF1 RBM15 SRSF5 POLDIP3 TEDC2 U2SURP SAE1 TFAP4 NPLOC4 ATOH8 | 5.10e-05 | 593 | 241 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | POU6F2 MAP1B LUZP1 NKX2-8 SAFB DDX46 BRCA2 NIPBL PHIP CASP8AP2 NRCAM PRR36 FAT3 FRYL ESF1 ZC3H12C MPHOSPH10 | 5.91e-05 | 498 | 241 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BRPF3 PPP2R2D TSPOAP1 PPP1R15A GPR179 LUZP1 BLM DDX46 BBX BRCA2 MCM3AP MKI67 TJP2 NIPBL PHIP BRWD1 TBX22 TICRR COL17A1 PRR36 ZDHHC5 DNM1L TSEN54 ESF1 SNCAIP EGR2 | 6.25e-05 | 989 | 241 | 26 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | BRPF3 VRK3 MCM8 MAP1B MYO5A TSPOAP1 CHD1 GPATCH8 TLK1 FAT1 BRCA2 MKI67 KDM2B NIPBL PHIP BRWD1 CASP8AP2 TICRR CDC42BPA PRR36 PHF12 FAT3 FRYL ZFC3H1 RFX5 LARP7 ESF1 CD4 ZFHX2 ZC3H12C MPHOSPH10 TP53BP1 | 8.33e-05 | 1370 | 241 | 32 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | DENND4A ABI3 MAP1B INPP5D ATP8B1 PPP1R15A DLC1 SVIL AMOTL1 NAV3 FGD5 JCAD DOCK9 VASH1 MYO18A FRYL SRGAP2 NIBAN2 ARHGEF15 EGR2 ROBO2 ZC3H12C PCDH1 | 1.05e-04 | 847 | 241 | 23 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MAP1B MYCBP2 KIF26A MARK1 SIPA1L3 CHD1 USP31 DLC1 BBX PHIP FAT4 SGIP1 COL17A1 ANK3 NRCAM TBC1D30 FAT3 C2CD3 TNFSF13B SIPA1L1 TNKS2 SON | 1.71e-04 | 818 | 241 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | MYCBP2 ASH1L CHD1 KMT2E TRIP12 KMT2C NIPBL PHIP DYNC1H1 FRYL ZFC3H1 ANKRD11 SCAF11 SRRM2 SON | 4.81e-13 | 200 | 247 | 15 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B ASH1L CHD1 KMT2E LUZP1 NIPBL PHIP ESF1 ANKRD11 SCAF11 SRRM2 PALLD SON | 4.93e-11 | 188 | 247 | 13 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B MYCBP2 ASH1L ZC3H3 KMT2C NAV2 DYNC1H1 FRYL ANKRD11 ROBO2 SCAF11 SRRM2 SON | 7.79e-11 | 195 | 247 | 13 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B MYCBP2 ASH1L ZC3H3 KMT2C NAV2 DYNC1H1 FRYL ANKRD11 ROBO2 TNKS2 SRRM2 SON | 7.79e-11 | 195 | 247 | 13 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | SRPK2 TRIP12 DDX46 MTUS1 NIPBL AP3D1 CDC42BPA RBBP6 U2SURP GLIS3 LARP7 ANKRD11 SCAF11 | 1.00e-10 | 199 | 247 | 13 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | MAP1B KMT2E BBX MTUS1 NIPBL BRWD1 CDC42BPA U2SURP LARP7 ZNF106 ANKRD11 ANKRD36 LRRFIP2 | 1.00e-10 | 199 | 247 | 13 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | ASH1L SRPK2 KMT2E TRIP12 LUZP1 MTUS1 NIPBL CDC42BPA RBBP6 ANKRD11 MPHOSPH10 | 3.40e-10 | 138 | 247 | 11 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MAP1B MYCBP2 KMT2E AMOTL1 TJP2 JCAD SH3PXD2A ANKRD11 SMARCA4 ROBO2 SON | 1.00e-08 | 190 | 247 | 11 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | DENND4A ASH1L CHD1 HELB KMT2C CRYBG1 ANK3 DOCK9 ANKRD36B PCNX1 ANKRD36 | 1.12e-08 | 192 | 247 | 11 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | ATXN7L1 ASH1L SRPK2 CDK14 SVIL FNDC3B ANK3 GLIS3 SIPA1L1 ANKRD11 EXOC4 | 1.12e-08 | 192 | 247 | 11 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | MYCBP2 SRPK2 CHD1 DNTTIP2 TLK1 NIPBL CDC42BPA RBBP6 ZNF106 ANKRD11 SCAF11 | 1.53e-08 | 198 | 247 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SLCO2B1 ASH1L KMT2C DLC1 NIPBL BRWD1 FAT4 DOCK9 VASH1 ARHGEF15 SON | 1.70e-08 | 200 | 247 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | MYCBP2 CHD1 PPP1R15A DNTTIP2 KMT2C NIPBL DYNC1H1 RBBP6 ANKRD11 SRRM2 SON | 1.70e-08 | 200 | 247 | 11 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | AMOTL1 FGD5 JCAD FAT4 COL17A1 TPPP ATP8B2 ARHGEF15 SNCAIP DCAF12L1 | 5.97e-08 | 177 | 247 | 10 | 8ef41ee5d63737b810ad7371b0437625e7e1badf |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 7.37e-08 | 181 | 247 | 10 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | C19orf47 ZMAT5 SORCS2 NPAS2 SRGAP2 CEP192 PTPN21 POLR3B ZZZ3 CFAP44 | 9.04e-08 | 185 | 247 | 10 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | C19orf47 ZMAT5 SORCS2 NPAS2 SRGAP2 CEP192 PTPN21 POLR3B ZZZ3 CFAP44 | 9.04e-08 | 185 | 247 | 10 | 02cbf492bc40abebaa93a3a208888afae72fbe06 |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.00e-07 | 187 | 247 | 10 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5A EML6 ATP8B1 SORCS2 CRYBG1 FGF12 ANK3 NRCAM COBLL1 GLIS3 | 1.05e-07 | 188 | 247 | 10 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | DENND4A ASH1L CHD1 KMT2C NIPBL DYNC1H1 ANKRD11 PCNX1 ANKRD36 TP53BP1 | 1.05e-07 | 188 | 247 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5A EML6 ATP8B1 SORCS2 CRYBG1 FGF12 NPAS2 ANK3 NRCAM COBLL1 | 1.10e-07 | 189 | 247 | 10 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-07 | 189 | 247 | 10 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-07 | 190 | 247 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5A EML6 ATP8B1 SORCS2 CRYBG1 FGF12 ANK3 NRCAM COBLL1 GLIS3 | 1.16e-07 | 190 | 247 | 10 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-07 | 191 | 247 | 10 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 CRYBG1 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.34e-07 | 193 | 247 | 10 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 CRYBG1 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 PCDH1 | 1.41e-07 | 194 | 247 | 10 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 CRYBG1 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.41e-07 | 194 | 247 | 10 | 53a5e8863d79a052dff0758f389be5ac3883c721 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.48e-07 | 195 | 247 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 PCDH1 | 1.48e-07 | 195 | 247 | 10 | 3826bfafe85f8aa9a508202ceb2b02e81b090498 |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-07 | 195 | 247 | 10 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | GPRASP1 ASH1L HELB SRSF5 ANK3 ZFC3H1 ATP8B2 ANKRD36B ANKRD11 ANKRD36 | 1.48e-07 | 195 | 247 | 10 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 CRYBG1 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.63e-07 | 197 | 247 | 10 | aedc1e3ed6b558bf2f7649919f43049f8348ab85 |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | SRPK2 TRIP12 NIPBL AP3D1 CDC42BPA RBBP6 GLIS3 ANKRD36B ANKRD11 ANKRD36 | 1.79e-07 | 199 | 247 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | GPRASP1 MAP1B MYO5A MYCBP2 SRPK2 PI4KA TCEAL6 AP3D1 SGIP1 KIF3A | 1.87e-07 | 200 | 247 | 10 | c888fd487990cad482a4ca47601cdebc0ca3f3ce |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | MAP1B MYCBP2 EML6 CDK14 FGF12 UNC79 ANK3 AFF3 ANKRD36B ANKRD36 | 1.87e-07 | 200 | 247 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.32e-07 | 156 | 247 | 9 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-07 | 181 | 247 | 9 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MAP1B KIF26A ATP8B1 LUZP1 FGD5 FAT4 TMEM255B ARHGEF15 SNCAIP | 8.10e-07 | 181 | 247 | 9 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-07 | 181 | 247 | 9 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-07 | 181 | 247 | 9 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-07 | 181 | 247 | 9 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-07 | 182 | 247 | 9 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MAP1B KIF26A ATP8B1 LUZP1 FGD5 FAT4 TMEM255B ARHGEF15 SNCAIP | 8.88e-07 | 183 | 247 | 9 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-07 | 184 | 247 | 9 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 185 | 247 | 9 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-07 | 185 | 247 | 9 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 185 | 247 | 9 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 187 | 247 | 9 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 187 | 247 | 9 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 187 | 247 | 9 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 187 | 247 | 9 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 PCDH1 | 1.11e-06 | 188 | 247 | 9 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 189 | 247 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-06 | 189 | 247 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.21e-06 | 190 | 247 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 191 | 247 | 9 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 191 | 247 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 191 | 247 | 9 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 191 | 247 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 192 | 247 | 9 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 192 | 247 | 9 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 192 | 247 | 9 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 192 | 247 | 9 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 192 | 247 | 9 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 192 | 247 | 9 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 MKI67 JCAD DOCK9 TMEM255B ARHGEF15 PCDH1 | 1.38e-06 | 193 | 247 | 9 | 643f992dbce639e7d147924d8b8f455fcebf215a |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 193 | 247 | 9 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.38e-06 | 193 | 247 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 193 | 247 | 9 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 193 | 247 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 193 | 247 | 9 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 193 | 247 | 9 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-06 | 193 | 247 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-06 | 194 | 247 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-06 | 194 | 247 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | DENND4A PPP1R15A CDK14 MAP3K1 COBLL1 AFF3 SRGAP2 SIPA1L1 PAX5 | 1.50e-06 | 195 | 247 | 9 | 481989d2e5bd2582da3d86b0155c4d6615317067 |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.50e-06 | 195 | 247 | 9 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.50e-06 | 195 | 247 | 9 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | DENND4A PPP1R15A CDK14 MAP3K1 COBLL1 AFF3 SRGAP2 SIPA1L1 PAX5 | 1.50e-06 | 195 | 247 | 9 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-06 | 196 | 247 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.57e-06 | 196 | 247 | 9 | 29ed8b1c4cd730db8632fde6eece404f1883a86d |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.57e-06 | 196 | 247 | 9 | c65b8c7ea34a21897c390e6fb42ee8ca41e9c976 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 196 | 247 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.57e-06 | 196 | 247 | 9 | 9ed96085f0acce07bf2f8d4cc212cc50e613be0c |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.57e-06 | 196 | 247 | 9 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.57e-06 | 196 | 247 | 9 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | PCW_10-12-Endothelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 NPAS2 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.57e-06 | 196 | 247 | 9 | 2c60dcf9132ee156f25b349e2ac5313709def4f6 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 197 | 247 | 9 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.64e-06 | 197 | 247 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SLCO2B1 INPP5D USP31 CRYBG1 JCAD DOCK9 VASH1 TMEM255B ARHGEF15 | 1.71e-06 | 198 | 247 | 9 | 8fb624407abb9cb711d8d8a8665014cf6e39559a |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-06 | 198 | 247 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 198 | 247 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.78e-06 | 199 | 247 | 9 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 247 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 247 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 247 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 247 | 9 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.51e-06 | 162 | 247 | 8 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-06 | 163 | 247 | 8 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | MYCBP2 SRPK2 GPATCH8 DLC1 AP3D1 DYNC1LI2 FNDC3B CDC42BPA MTF2 RBBP6 ESF1 ANKRD11 SMARCA4 SCAF11 SRRM2 SON | 9.96e-11 | 177 | 246 | 16 | 985_DN |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | MYCBP2 GPATCH8 BBX AP3D1 FNDC3B CDC42BPA ANK3 MTF2 ESF1 ANKRD11 SMARCA4 SCAF11 SRRM2 SON | 9.92e-09 | 179 | 246 | 14 | 4585_DN |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | DENND4A ZC3H3 CIC GLYR1 NIPBL AP3D1 BRWD1 CDC42BPA SRSF5 NRCAM SRGAP2 ANKRD11 BICRAL | 1.73e-07 | 191 | 246 | 13 | 2857_DN |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | MYCBP2 SRPK2 BBX AP3D1 CDC42BPA MTF2 RBBP6 ESF1 ANKRD11 SCAF11 SRRM2 SON | 5.75e-07 | 178 | 246 | 12 | 3998_DN |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | GPRASP1 INCENP VWA8 PACSIN3 PPP1R15A FBXO38 SAFB BRCA2 NPAS2 NUMA1 SMARCA4 PCNX1 | 1.22e-06 | 191 | 246 | 12 | 4647_DN |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | LSG1 CREBZF MKI67 NIPBL BRWD1 NPAT CDC42BPA TEDC2 U2SURP FRYL MARK2 SRRM2 | 1.68e-06 | 197 | 246 | 12 | 2070_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | SRPK2 EYA2 TLK1 SVIL NIPBL NPAT TBC1D30 DOCK9 COBLL1 FRYL POLR3B | 3.20e-06 | 174 | 246 | 11 | 7530_DN |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | SYNRG VRK3 ZMYND8 ZNF318 ATP8B1 NPAS2 NPAT RBBP6 ZFC3H1 ANKRD11 MPHOSPH10 | 4.68e-06 | 181 | 246 | 11 | 1791_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | ZMYND8 SRPK2 CHD1 TLK1 BBX NIPBL FNDC3B TBC1D30 MTF2 FRYL SCAF11 | 5.21e-06 | 183 | 246 | 11 | 7498_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | SYNRG ABL1 ZMYND8 CHD1 BRCA2 NIPBL NPAT RBM15 TBC1D30 MTF2 POLR3B | 5.48e-06 | 184 | 246 | 11 | 2321_DN |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | TLK1 KIF3C NIPBL BRWD1 SRSF5 DOCK9 U2SURP KIF3A C2CD3 SIPA1L1 SON | 5.78e-06 | 185 | 246 | 11 | 7209_DN |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | GPRASP1 SYNRG ZMYND8 ZNF318 SLC35D1 GLYR1 MKI67 BRWD1 COBLL1 ZNF106 SCAF11 | 7.83e-06 | 191 | 246 | 11 | 4168_DN |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; PC3; HT_HG-U133A | SIPA1L3 ZMAT5 NAV3 NAV2 KIF3C ANK3 TBC1D30 POLDIP3 NCKIPSD PTPN21 ARHGAP35 | 8.64e-06 | 193 | 246 | 11 | 4671_DN |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | CREBZF GLYR1 MCM3AP CNOT3 PPFIBP2 VASH1 ARHGAP35 ATP8B2 PCNX1 MARK2 CFAP44 | 9.08e-06 | 194 | 246 | 11 | 3619_DN |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | UBE4B VWA8 NAV3 NAV2 NIPBL BRWD1 JCAD U2SURP ARHGAP35 PCNX1 BICRAL | 9.08e-06 | 194 | 246 | 11 | 4662_DN |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | MAP1B SIPA1L3 TMC6 ZC3H3 SVIL KIF3C NPAS2 TEDC2 TNKS2 CFAP44 SRRM2 | 1.00e-05 | 196 | 246 | 11 | 7124_DN |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A | DENND4A UBE4B GON4L SRPK2 ZNF318 MTUS1 JCAD MTF2 ARHGAP35 NCOR2 SIPA1L1 | 1.00e-05 | 196 | 246 | 11 | 6323_DN |
| Drug | DAPH; Down 200; 10uM; MCF7; HG-U133A | MYO5A UBE4B MYCBP2 SRPK2 CIC MTUS1 C2orf49 NIPBL SMARCA4 DYNC1LI1 SCAF11 | 1.05e-05 | 197 | 246 | 11 | 624_DN |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A | VWA8 SLC35D1 FBXO38 MCM3AP NIPBL NPAT MTF2 R3HCC1 FRYL DYNC1LI1 SCAF11 | 1.05e-05 | 197 | 246 | 11 | 1386_DN |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A | SIPA1L3 MTUS1 GLYR1 BRWD1 NRCAM TEDC2 PTPN21 ARHGAP35 CD4 PAX5 SRRM2 | 1.05e-05 | 197 | 246 | 11 | 7311_UP |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | SYNRG UBE4B SIPA1L3 BRAP ZMAT5 BRCA2 MTUS1 CDC42BPA MTF2 ZNF106 LRRFIP2 | 1.05e-05 | 197 | 246 | 11 | 6240_DN |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | POU6F2 INCENP VWA8 CREBZF TLK1 MCM3AP LMOD1 ARHGEF15 NCOR2 SIPA1L1 PAX5 | 1.10e-05 | 198 | 246 | 11 | 3004_UP |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | VRK3 UBE4B MYCBP2 EYA2 CIC SLC35D1 MTUS1 MKI67 NIPBL EXOSC10 CEP192 | 1.15e-05 | 199 | 246 | 11 | 122_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | TLK1 SAFB MKI67 NIPBL EXOSC10 POLDIP3 SMARCAL1 LARP7 SIPA1L1 SON | 3.04e-05 | 182 | 246 | 10 | 1891_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.04e-05 | 182 | 246 | 10 | 3887_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | CREBZF BRCA2 BRWD1 NPAT TBC1D30 MTF2 TEDC2 PALB2 MPHOSPH10 SON | 3.19e-05 | 183 | 246 | 10 | 3232_DN |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | ZMYND8 CHD1 CREBZF DLC1 NIPBL MTF2 PALB2 POLR3B MPHOSPH10 SON | 3.50e-05 | 185 | 246 | 10 | 1114_DN |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | ASH1L GPATCH8 AP3D1 CDC42BPA TBC1D30 NUMA1 PTPN21 TFAP4 ANKRD11 SCAF11 | 4.59e-05 | 191 | 246 | 10 | 6020_DN |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | MAP1B UBE4B SIPA1L3 ATP8B1 CREBZF CDC42BPA ARHGAP35 TFAP4 PCNX1 PAX5 | 4.59e-05 | 191 | 246 | 10 | 5997_DN |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A | DENND4A INCENP VWA8 TMC6 FBXO38 BRCA2 NPAS2 ANK3 ARHGAP35 LRP1 | 5.01e-05 | 193 | 246 | 10 | 4650_DN |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A | DENND4A INCENP VWA8 PPP1R15A MTUS1 SVIL JCAD TEDC2 U2SURP ARHGAP35 | 5.23e-05 | 194 | 246 | 10 | 4648_DN |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | CREBZF SLC35D1 DLC1 GLYR1 MCM3AP KIF3C ATP8B2 PCNX1 TNKS2 CFAP44 | 5.46e-05 | 195 | 246 | 10 | 4740_DN |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | PPP2R2D TMC6 LUZP1 FBXO38 NAV2 AP3D1 TEDC2 ARHGAP35 PAX5 PCDH1 | 5.46e-05 | 195 | 246 | 10 | 311_UP |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; PC3; HG-U133A | INCENP UBE4B SRPK2 LUZP1 AP3D1 NPAS2 U2SURP NUMA1 SIPA1L1 DYNC1LI1 | 5.46e-05 | 195 | 246 | 10 | 434_DN |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | TMC6 ZNF318 EYA2 LUZP1 BRCA2 U2SURP ATP8B2 TFAP4 ZNF106 GPR153 | 5.46e-05 | 195 | 246 | 10 | 7426_DN |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | ZNF318 ATP8B1 SAFB SVIL BRWD1 TEDC2 SMARCAL1 U2SURP CEP192 BICRAL | 5.46e-05 | 195 | 246 | 10 | 6938_DN |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | UBE4B ZNF318 EYA2 LUZP1 PI4KA GLYR1 NPAT CDC42BPA NUMA1 BICRAL | 5.46e-05 | 195 | 246 | 10 | 7327_DN |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | TMC6 ZMYND8 ASH1L LRRC2 SVEP1 DLC1 MTUS1 MCM3AP CDC42BPA U2SURP | 5.70e-05 | 196 | 246 | 10 | 4100_DN |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | UBE4B TMC6 EVC ZC3H3 SVIL CDC42BPA TEDC2 U2SURP GPR153 SRRM2 | 5.70e-05 | 196 | 246 | 10 | 7382_DN |
| Drug | sulfasalazine; Down 200; 100uM; MCF7; HG-U133A | GPRASP1 SYNRG SRPK2 ATP8B1 CIC LUZP1 SLC35D1 SH3PXD2A ZFHX2 PCNX1 | 5.70e-05 | 196 | 246 | 10 | 204_DN |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | MAP1B ZC3H3 CIC DLC1 FGF12 CNOT3 CDC42BPA COBLL1 GPR153 PCDH1 | 5.70e-05 | 196 | 246 | 10 | 2296_UP |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | SAFB KIF3C AP3D1 CDC42BPA MTF2 COBLL1 U2SURP FRYL MARK2 LRRFIP2 | 5.95e-05 | 197 | 246 | 10 | 6218_DN |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | MARK1 TLK1 BRCA2 NPAS2 COBLL1 PTPN21 ARHGAP35 PCNX1 MARK2 PCDH1 | 5.95e-05 | 197 | 246 | 10 | 3798_DN |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | TMC6 CIC BRCA2 MCM3AP CDC42BPA NUMA1 PTPN21 MAP1S PCNX1 BICRAL | 5.95e-05 | 197 | 246 | 10 | 5999_DN |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 6.21e-05 | 198 | 246 | 10 | 5829_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A | ABL1 ASH1L ZNF318 LUZP1 KIF3C R3HCC1 ARHGAP35 TFAP4 DYNC1LI1 CEP170B | 6.21e-05 | 198 | 246 | 10 | 782_DN |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A | DENND4A MAP1B PPP2R2D ZMYND8 EVC ZMAT5 BRCA2 MTUS1 NPAS2 SRGAP2 | 6.21e-05 | 198 | 246 | 10 | 5742_DN |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | TMC6 ZNF318 CREBZF BRCA2 GLYR1 CNOT3 MTF2 ARHGAP35 BICRAL PAX5 | 6.21e-05 | 198 | 246 | 10 | 7012_UP |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 6.48e-05 | 199 | 246 | 10 | 3307_DN | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; PC3; HT_HG-U133A | UBE4B PPP1R15A BRAP ZMAT5 MTUS1 BRWD1 U2SURP PTPN21 CFAP44 SRRM2 | 6.48e-05 | 199 | 246 | 10 | 4603_DN |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; PC3; HT_HG-U133A | GPRASP1 TMC6 ZMYND8 LRRC2 NPAS2 TBC1D30 NUMA1 PHF7 NCOR2 LRP1 | 6.48e-05 | 199 | 246 | 10 | 4064_DN |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | DENND4A VWA8 SVIL NAV2 CDC42BPA PRR36 PTPN21 GPR153 ZFHX2 SRRM2 | 6.48e-05 | 199 | 246 | 10 | 2319_DN |
| Drug | Calciferol [50-14-6]; Down 200; 10uM; HL60; HT_HG-U133A | CDC42BPA PPFIBP2 TEDC2 COBLL1 ARHGAP35 ATP8B2 TFAP4 CNNM1 MAP1S CEP170B | 6.48e-05 | 199 | 246 | 10 | 2442_DN |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; HL60; HG-U133A | VRK3 MYO5A CREBZF BRAP SVIL C2orf49 AP3D1 EXOSC10 SMARCAL1 SON | 6.48e-05 | 199 | 246 | 10 | 1391_DN |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 6.48e-05 | 199 | 246 | 10 | 6936_DN | |
| Drug | tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A | VRK3 VWA8 CIC LUZP1 TJP2 ANK3 DYNC1LI1 PCNX1 TP53BP1 LRRFIP2 | 6.48e-05 | 199 | 246 | 10 | 143_UP |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | SYNRG UBE4B GON4L ZNF318 SAFB CNOT3 NPAS2 ARHGAP35 NCOR2 LRP1 | 6.48e-05 | 199 | 246 | 10 | 4649_DN |
| Drug | Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | CDK14 SVEP1 TLK1 GLYR1 FGF12 PPFIBP2 NUMA1 SH3D21 CNNM1 ZFHX2 | 6.48e-05 | 199 | 246 | 10 | 3271_UP |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | LUZP1 SAFB CDC42BPA MTF2 TEDC2 COBLL1 U2SURP R3HCC1 ATP8B2 SRRM2 | 6.75e-05 | 200 | 246 | 10 | 7015_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.01e-04 | 170 | 246 | 9 | 3791_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | NAV2 NIPBL NPAS2 FNDC3B CEP192 POLR3B SIPA1L1 ANKRD11 LRRFIP2 | 1.06e-04 | 171 | 246 | 9 | 7535_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.15e-04 | 173 | 246 | 9 | 4665_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.21e-04 | 174 | 246 | 9 | 1302_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.50e-04 | 179 | 246 | 9 | 2105_DN | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.63e-04 | 181 | 246 | 9 | 3275_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.69e-04 | 182 | 246 | 9 | 3630_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.69e-04 | 182 | 246 | 9 | 5802_DN | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.77e-04 | 183 | 246 | 9 | 2750_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.77e-04 | 183 | 246 | 9 | 7062_DN | |
| Drug | clotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA | GPRASP1 MAP1B PPP1R15A MCM3AP FNDC3B ANK3 COBLL1 CNNM1 SIPA1L1 | 1.92e-04 | 185 | 246 | 9 | 905_UP |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.92e-04 | 185 | 246 | 9 | 1673_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.99e-04 | 186 | 246 | 9 | 6874_DN | |
| Drug | Magnetite Nanoparticles | TSPOAP1 INPP5D ZMYND8 ASH1L SRPK2 KMT2E BLM DDX46 BRCA2 ZFYVE21 MKI67 NAV2 KIF3C PHIP BRWD1 NPAS2 CASP8AP2 CDC42BPA ANK3 MTF2 RBBP6 PPFIBP2 ZFC3H1 KIF3A EGR2 TNFSF13B LRP1 ZC3H12C TNKS2 | 2.01e-04 | 1310 | 246 | 29 | ctd:D058185 |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | INPP5D SIPA1L3 SVIL PLCB2 TBC1D30 U2SURP ARHGAP35 NCOR2 MAP1S | 2.16e-04 | 188 | 246 | 9 | 1176_DN |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; PC3; HT_HG-U133A | 2.25e-04 | 189 | 246 | 9 | 3771_DN | |
| Drug | nocodazole | SYNRG MAP1B INCENP MYO5A PPP2R2D KMT2E CDK14 MAP3K1 DYNC1H1 NCAPD3 COPB1 RBBP6 NUMA1 MYO18A MAP1S | 2.32e-04 | 477 | 246 | 15 | CID000004122 |
| Drug | Gramine [87-52-5]; Up 200; 23uM; HL60; HT_HG-U133A | GPRASP1 SIPA1L3 ZMAT5 MTUS1 CDC42BPA SRSF5 AFF3 NUMA1 SH3D21 | 2.34e-04 | 190 | 246 | 9 | 2143_UP |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.34e-04 | 190 | 246 | 9 | 3373_DN | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.34e-04 | 190 | 246 | 9 | 952_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | CREBZF MCM3AP MKI67 TBC1D30 U2SURP NUMA1 TFAP4 SMARCA4 SRRM2 | 2.43e-04 | 191 | 246 | 9 | 4454_DN |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | CREBZF SLC35D1 TLK1 PRR36 PPFIBP2 COBLL1 GPR153 MARK2 CFAP44 | 2.43e-04 | 191 | 246 | 9 | 3975_DN |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | GPRASP1 TSPOAP1 SNX19 CREBZF GLYR1 ANAPC2 KIF3C SRSF5 TBC1D30 | 2.43e-04 | 191 | 246 | 9 | 2937_DN |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.43e-04 | 191 | 246 | 9 | 7435_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | INCENP LUZP1 FBXO38 GLYR1 MCM3AP CDC42BPA POLDIP3 NUMA1 ARHGAP35 | 2.53e-04 | 192 | 246 | 9 | 2766_DN |
| Drug | Succimer | TSPOAP1 INPP5D ZMYND8 ASH1L SRPK2 KMT2E BLM DDX46 BRCA2 ZFYVE21 MKI67 NAV2 KIF3C PHIP BRWD1 NPAS2 CASP8AP2 CDC42BPA ANK3 MTF2 RBBP6 PPFIBP2 ZFC3H1 EGR2 TNFSF13B LRP1 ZC3H12C TNKS2 | 2.58e-04 | 1264 | 246 | 28 | ctd:D004113 |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | 2.62e-04 | 193 | 246 | 9 | 6604_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.62e-04 | 193 | 246 | 9 | 3906_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | SYNRG ZMYND8 ZNF318 NIPBL DOCK9 SMARCAL1 ZFC3H1 KIF3A TP53BP1 | 2.73e-04 | 194 | 246 | 9 | 1670_DN |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | LUZP1 GLYR1 CDC42BPA PPFIBP2 PTPN21 ARHGAP35 CD4 SIPA1L1 SRRM2 | 2.73e-04 | 194 | 246 | 9 | 3321_DN |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 2.73e-04 | 194 | 246 | 9 | 4159_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.73e-04 | 194 | 246 | 9 | 5826_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.73e-04 | 194 | 246 | 9 | 7098_DN | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.83e-04 | 195 | 246 | 9 | 3320_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 2.83e-04 | 195 | 246 | 9 | 5241_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.83e-04 | 195 | 246 | 9 | 6654_DN | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.83e-04 | 195 | 246 | 9 | 7403_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.83e-04 | 195 | 246 | 9 | 5330_UP | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 2.83e-04 | 195 | 246 | 9 | 667_DN | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 2.83e-04 | 195 | 246 | 9 | 166_UP | |
| Drug | ICRF-193 | 2.90e-04 | 54 | 246 | 5 | CID000115150 | |
| Disease | serum gamma-glutamyl transferase measurement | SIPA1L3 ASH1L GON4L ATP8B1 SVIL NAV2 KDM2B JCAD NYAP2 SGIP1 CDC42BPA MTF2 COBLL1 GLIS3 ARHGAP35 ARHGEF15 NCOR2 ZZZ3 MAP1S RP1L1 TP53BP1 EXOC4 | 5.26e-06 | 914 | 237 | 22 | EFO_0004532 |
| Disease | platelet component distribution width | ZMYND8 SVEP1 TLK1 KIF9 DLC1 C22orf31 SVIL BRWD1 NPAS2 JCAD NYAP2 DOCK9 COBLL1 U2SURP DNM1L ARHGEF15 NCOR2 TNFSF13B LRRC71 | 1.28e-05 | 755 | 237 | 19 | EFO_0007984 |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.30e-05 | 111 | 237 | 7 | EFO_0004530, EFO_0008595 | |
| Disease | Pancreatic carcinoma, familial | 4.15e-05 | 9 | 237 | 3 | C2931038 | |
| Disease | waist-hip ratio | MYCBP2 ATXN7L1 SRPK2 ZNF318 EYA2 TRIP12 KIF9 DLC1 BBX NAV3 PIPSL PHIP AP3D1 NPAS2 JCAD FNDC3B NYAP2 ANK3 COPB1 COBLL1 AFF3 SRGAP2 CEP192 PCNX1 | 5.70e-05 | 1226 | 237 | 24 | EFO_0004343 |
| Disease | FEV/FEC ratio | HMGN1 MAP3K1 DLC1 MTUS1 SVIL NAV2 LMOD1 AP3D1 JCAD FNDC3B DOCK9 U2SURP AFF3 GLIS3 TPPP TSEN54 SRGAP2 TFAP4 SH3D21 NPLOC4 ZNF106 SH3PXD2A ANKRD11 LRP1 | 5.85e-05 | 1228 | 237 | 24 | EFO_0004713 |
| Disease | pulse pressure measurement | BRPF3 MAP1B H1-7 ZNF318 GPATCH8 CDK14 SNX19 SVEP1 LUZP1 FBXO38 DLC1 FGD5 AP3D1 NPAS2 JCAD FNDC3B NYAP2 SGIP1 FAT3 COBLL1 FRYL ANKRD11 LRP1 PALLD LRRFIP2 MYBPC3 | 6.01e-05 | 1392 | 237 | 26 | EFO_0005763 |
| Disease | cortical thickness | MYCBP2 ZNF318 MAP3K1 LUZP1 DLC1 PI4KA GLYR1 NAV3 NAV2 NYAP2 FAT3 DOCK9 SMARCAL1 GLIS3 SRGAP2 ARHGAP35 TFAP4 ZNF106 SH3PXD2A LRP1 ROBO2 EXOC4 | 1.02e-04 | 1113 | 237 | 22 | EFO_0004840 |
| Disease | Neurodevelopmental Disorders | 1.07e-04 | 93 | 237 | 6 | C1535926 | |
| Disease | electrocardiography | MYCBP2 LUZP1 SVIL NAV2 JCAD FNDC3B SGIP1 ZDHHC5 ZFC3H1 SH3PXD2A SIPA1L1 PCNX1 PALLD MYBPC3 | 1.09e-04 | 530 | 237 | 14 | EFO_0004327 |
| Disease | reticulocyte measurement | DENND4A VWA8 INPP5D TMC6 EML6 ASH1L EYA2 PPP1R15A MAP3K1 BRAP FAT1 C22orf31 OXSR1 FNDC3B NYAP2 COPB1 COBLL1 U2SURP AFF3 SH3D21 ARHGEF15 | 1.31e-04 | 1053 | 237 | 21 | EFO_0010700 |
| Disease | Profound Mental Retardation | 1.37e-04 | 139 | 237 | 7 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.37e-04 | 139 | 237 | 7 | C0025363 | |
| Disease | Mental deficiency | 1.37e-04 | 139 | 237 | 7 | C0917816 | |
| Disease | neuroimaging measurement | MAP1B MAP3K1 LUZP1 SLC35D1 NAV3 NAV2 CDC42BPA ANK3 FAT3 DOCK9 AFF3 ZDHHC5 GLIS3 FRYL PTPN21 ARHGAP35 TFAP4 ZNF106 SH3PXD2A ROBO2 EXOC4 | 1.61e-04 | 1069 | 237 | 21 | EFO_0004346 |
| Disease | Bell's palsy | 1.78e-04 | 102 | 237 | 6 | EFO_0007167 | |
| Disease | white matter hyperintensity measurement | GON4L QRICH2 MAP3K1 NRCAM TSEN54 ARHGAP35 NCOR2 ZNF106 SNCAIP SH3PXD2A | 1.80e-04 | 302 | 237 | 10 | EFO_0005665 |
| Disease | hematocrit | BRPF3 H1-7 TMC6 ASH1L ATP8B1 BRAP FAT1 ZFYVE21 FGD5 AP3D1 JCAD NYAP2 COBLL1 AFF3 GLIS3 SAE1 ARHGEF15 NCOR2 EGR2 TP53BP1 | 2.10e-04 | 1011 | 237 | 20 | EFO_0004348 |
| Disease | mean platelet volume | MYO5A EML6 ZMYND8 HMGN1 SVEP1 TLK1 BBX PI4KA SVIL BIN2 PHIP JCAD U2SURP AFF3 NUMA1 DNM1L FRYL TFAP4 ANKRD11 MYBPC3 | 2.36e-04 | 1020 | 237 | 20 | EFO_0004584 |
| Disease | leptin measurement, type 2 diabetes mellitus | 2.65e-04 | 16 | 237 | 3 | EFO_0005000, MONDO_0005148 | |
| Disease | intraocular pressure measurement | POU6F2 BRAP DLC1 NPAS2 JCAD FNDC3B EXOSC10 AFF3 GLIS3 NPLOC4 ZNF106 SH3PXD2A MYBPC3 | 2.66e-04 | 509 | 237 | 13 | EFO_0004695 |
| Disease | platelet crit | KIF26A TMC6 HMGN1 ZNF318 GPATCH8 BRAP BBX SVIL NAV3 NPAT JCAD NYAP2 SRSF5 U2SURP AFF3 TSEN54 NIBAN2 SH3D21 TNFSF13B | 2.72e-04 | 952 | 237 | 19 | EFO_0007985 |
| Disease | coronary artery disease | MAP1B INPP5D LRRC2 SVEP1 MAP3K1 DLC1 LMOD1 C2 PLCB2 FGD5 JCAD FNDC3B FAT4 NYAP2 DOCK9 MAP1S LRP1 SMARCA4 SCAF11 MPHOSPH10 PAX5 PALLD | 2.74e-04 | 1194 | 237 | 22 | EFO_0001645 |
| Disease | Intellectual Disability | MAP1B ASH1L GON4L KMT2E CIC KMT2C PHIP DYNC1H1 AFF3 TSEN54 LARP7 POLR3B | 2.92e-04 | 447 | 237 | 12 | C3714756 |
| Disease | retinal vasculature measurement | MYO5A LUZP1 NAV3 TJP2 LMOD1 CDC42BPA AFF3 NIBAN2 NPLOC4 ZNF106 POLR3B SH3PXD2A PALLD | 3.08e-04 | 517 | 237 | 13 | EFO_0010554 |
| Disease | venous thromboembolism | TSPOAP1 ATXN7L1 PACSIN3 ZC3H3 ZNF71 DLC1 NAV2 BRWD1 ANK3 TOGARAM2 TNFSF13B SRRM2 | 3.77e-04 | 460 | 237 | 12 | EFO_0004286 |
| Disease | Clinodactyly | 3.81e-04 | 4 | 237 | 2 | C4551485 | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 3.81e-04 | 4 | 237 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | Clinodactyly of fingers | 3.81e-04 | 4 | 237 | 2 | C0265610 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 4.06e-04 | 166 | 237 | 7 | EFO_0004530, EFO_0004611 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | ZNF318 SVEP1 TJP2 KDM2B FGD5 TICRR NYAP2 SMARCA4 PCNX1 MYBPC3 | 4.09e-04 | 335 | 237 | 10 | EFO_0009931 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 4.28e-04 | 220 | 237 | 8 | EFO_0004529, EFO_0008317 | |
| Disease | emphysema pattern measurement | 4.51e-04 | 19 | 237 | 3 | EFO_0005850 | |
| Disease | Malignant neoplasm of breast | ABL1 SLCO2B1 ZNF318 ATP8B1 CIC MAP3K1 BRCA2 MKI67 FGD5 NIPBL FNDC3B GFRAL NRCAM SMARCAL1 PHF7 PALB2 CUTC SIPA1L1 USP54 TP53BP1 | 4.56e-04 | 1074 | 237 | 20 | C0006142 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.67e-04 | 45 | 237 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | GPATCH8 MAP3K1 LUZP1 NAV3 NAV2 ANK3 COPB1 FAT3 GLIS3 TFAP4 SH3PXD2A ROBO2 EXOC4 | 5.51e-04 | 550 | 237 | 13 | EFO_0004346, EFO_0004464 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 5.58e-04 | 229 | 237 | 8 | EFO_0004639, EFO_0008317 | |
| Disease | myocardial infarction | BRAP PLCB2 FGD5 AP3D1 JCAD FNDC3B NYAP2 DOCK9 NCKIPSD SMARCA4 | 5.75e-04 | 350 | 237 | 10 | EFO_0000612 |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.80e-04 | 127 | 237 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | triglyceride measurement, body fat percentage | 6.11e-04 | 21 | 237 | 3 | EFO_0004530, EFO_0007800 | |
| Disease | hepatitis C virus infection, response to protease inhibitor, bilirubin measurement | 6.32e-04 | 5 | 237 | 2 | EFO_0003047, EFO_0004570, EFO_0005657 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 6.32e-04 | 5 | 237 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | non-high density lipoprotein cholesterol measurement | HMGN1 ATP8B1 ZMAT5 DLC1 BRCA2 SORCS2 C2 BRWD1 NYAP2 COBLL1 GLIS3 ARHGEF15 ZZZ3 SMARCA4 MARK2 | 7.05e-04 | 713 | 237 | 15 | EFO_0005689 |
| Disease | triglycerides to total lipids in large LDL percentage | 7.54e-04 | 51 | 237 | 4 | EFO_0022331 | |
| Disease | peak expiratory flow | SRPK2 EYA2 KMT2E DLC1 SVIL JCAD FNDC3B ANK3 DOCK9 GLIS3 TFAP4 LRP1 | 7.58e-04 | 498 | 237 | 12 | EFO_0009718 |
| Disease | cup-to-disc ratio measurement | EYA2 MTUS1 AMOTL1 NAV2 FAT4 ANK3 NCKIPSD ARHGAP35 NPLOC4 SNCAIP MARK2 | 7.71e-04 | 430 | 237 | 11 | EFO_0006939 |
| Disease | body fat percentage, fasting blood insulin measurement | 9.43e-04 | 6 | 237 | 2 | EFO_0004466, EFO_0007800 | |
| Disease | eye disease (implicated_via_orthology) | 9.43e-04 | 6 | 237 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | monocyte count | DENND4A TSPOAP1 INPP5D ASH1L GON4L CIC SLC35D1 BBX PI4KA USF1 AP3D1 NPAT JCAD NYAP2 CDC42BPA MTF2 U2SURP GLIS3 SAE1 NCOR2 TNFSF13B MYBPC3 | 1.04e-03 | 1320 | 237 | 22 | EFO_0005091 |
| Disease | glucose measurement | MYCBP2 VWA8 EML6 KDM2B FGF12 SGIP1 PPFIBP2 COBLL1 GLIS3 MYBPC3 | 1.07e-03 | 380 | 237 | 10 | EFO_0004468 |
| Disease | cholesterol to total lipids in large LDL percentage | 1.07e-03 | 56 | 237 | 4 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.15e-03 | 57 | 237 | 4 | EFO_0022284 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.16e-03 | 145 | 237 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | triglyceride measurement, alcohol drinking | 1.24e-03 | 99 | 237 | 5 | EFO_0004329, EFO_0004530 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.27e-03 | 260 | 237 | 8 | EFO_0008317 | |
| Disease | Bone Diseases, Developmental | 1.30e-03 | 27 | 237 | 3 | C0005941 | |
| Disease | Autistic Disorder | 1.30e-03 | 261 | 237 | 8 | C0004352 | |
| Disease | Adenoid Cystic Carcinoma | 1.30e-03 | 100 | 237 | 5 | C0010606 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.31e-03 | 59 | 237 | 4 | EFO_0022248 | |
| Disease | Headache, HOMA-B | 1.31e-03 | 7 | 237 | 2 | EFO_0004469, HP_0002315 | |
| Disease | Intrahepatic Cholestasis | 1.31e-03 | 7 | 237 | 2 | C0008372 | |
| Disease | cortical surface area measurement | MYCBP2 SRPK2 SVEP1 MAP3K1 LUZP1 NAV3 NAV2 TICRR NCAPD3 NYAP2 ANK3 COPB1 FAT3 DOCK9 GLIS3 FRYL TFAP4 NPLOC4 ZNF106 RP1L1 MDC1 ROBO2 | 1.32e-03 | 1345 | 237 | 22 | EFO_0010736 |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.36e-03 | 101 | 237 | 5 | EFO_0004530, EFO_0007878 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.39e-03 | 60 | 237 | 4 | EFO_0022330 | |
| Disease | uric acid measurement | SIPA1L3 TMC6 ZNF318 QRICH2 BRAP OXSR1 NPAS2 FAT4 NYAP2 CDC42BPA FAT3 COBLL1 ZDHHC5 | 1.41e-03 | 610 | 237 | 13 | EFO_0004761 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.48e-03 | 103 | 237 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | cancer (implicated_via_orthology) | 1.53e-03 | 268 | 237 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | testosterone measurement | DENND4A MYO5A ZNF318 FBXO38 BBX C2 PHIP BRWD1 NYAP2 ANK3 COBLL1 GLIS3 SAE1 NIBAN2 PTPN21 ARHGEF15 NCOR2 EGR2 SH3PXD2A TNKS2 MUCL3 | 1.56e-03 | 1275 | 237 | 21 | EFO_0004908 |
| Disease | hypertension, white matter hyperintensity measurement | 1.57e-03 | 62 | 237 | 4 | EFO_0000537, EFO_0005665 | |
| Disease | Miller Dieker syndrome | 1.60e-03 | 29 | 237 | 3 | C0265219 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.67e-03 | 63 | 237 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.67e-03 | 63 | 237 | 4 | EFO_0022239 | |
| Disease | Nephroblastoma | 1.74e-03 | 8 | 237 | 2 | cv:C0027708 | |
| Disease | Hereditary Wilms tumor | 1.74e-03 | 8 | 237 | 2 | cv:C0677779 | |
| Disease | Kidney Wilms tumor | 1.74e-03 | 8 | 237 | 2 | cv:CN305775 | |
| Disease | age at initiation of corrective lens use | 1.74e-03 | 8 | 237 | 2 | EFO_0021781 | |
| Disease | neutrophil count | DENND4A PPP2R2D MYCBP2 TSPOAP1 LSG1 INPP5D EML6 ASH1L SRPK2 KMT2E CIC BBX PLCB2 AP3D1 JCAD SGIP1 CDC42BPA TNFSF13B RP1L1 ANKRD11 CLMP TNKS2 | 1.85e-03 | 1382 | 237 | 22 | EFO_0004833 |
| Disease | Severe Congenital Microcephaly | 1.95e-03 | 31 | 237 | 3 | C3853041 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.04e-03 | 346 | 237 | 9 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | large artery stroke | 2.23e-03 | 113 | 237 | 5 | EFO_0005524 | |
| Disease | Liver Diseases, Parasitic | 2.23e-03 | 9 | 237 | 2 | C0023897 | |
| Disease | R-6-hydroxywarfarin measurement | 2.31e-03 | 114 | 237 | 5 | EFO_0803327 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.33e-03 | 69 | 237 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.33e-03 | 69 | 237 | 4 | EFO_0022341 | |
| Disease | Microlissencephaly | 2.34e-03 | 33 | 237 | 3 | C1956147 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.56e-03 | 291 | 237 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | posterior thigh muscle fat infiltration measurement | 2.77e-03 | 35 | 237 | 3 | EFO_0020934 | |
| Disease | immature platelet measurement | 2.79e-03 | 119 | 237 | 5 | EFO_0803541 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.99e-03 | 121 | 237 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | Nephroblastoma | 3.00e-03 | 36 | 237 | 3 | C0027708 | |
| Disease | Burkitt Lymphoma | 3.00e-03 | 36 | 237 | 3 | C0006413 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 3.16e-03 | 75 | 237 | 4 | EFO_0022287 | |
| Disease | age at menopause | 3.20e-03 | 302 | 237 | 8 | EFO_0004704 | |
| Disease | household income | 3.34e-03 | 304 | 237 | 8 | EFO_0009695 | |
| Disease | hypertension | 3.54e-03 | 307 | 237 | 8 | EFO_0000537 | |
| Disease | lymphocyte count | SYNRG ABL1 UBE4B EML6 C19orf47 TRIP12 ZNF71 SLC35D1 ZMAT5 MCM3AP AP3D1 JCAD NYAP2 COBLL1 GLIS3 SAE1 ARHGEF15 EGR2 TNFSF13B ANKRD11 ROBO2 MUCL3 | 3.70e-03 | 1464 | 237 | 22 | EFO_0004587 |
| Disease | corneal resistance factor | 3.72e-03 | 451 | 237 | 10 | EFO_0010067 | |
| Disease | C-reactive protein measurement | PPP2R2D UBE4B TRIP12 MAP3K1 TLK1 KDM2B DYNC1LI2 SGIP1 ANK3 MTF2 COBLL1 CEP192 ATP8B2 ZNF106 RP1L1 SMARCA4 SCAF11 TP53BP1 MYBPC3 | 4.18e-03 | 1206 | 237 | 19 | EFO_0004458 |
| Disease | ovarian neoplasm | 4.62e-03 | 134 | 237 | 5 | C0919267 | |
| Disease | Charcot-Marie-Tooth disease | 4.66e-03 | 42 | 237 | 3 | cv:C0007959 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSRSPVDLRGKSKDR | 291 | Q13523 | |
| KDASSGKENRSPSRR | 331 | Q13523 | |
| KRDKRSADKLTPAGS | 1406 | Q68DN1 | |
| RSAGKKPTRRTERTS | 581 | P51826 | |
| ETKRSSTVDGLRKRP | 86 | Q9BVC5 | |
| VKRLLKGSRSASVSP | 161 | Q9UMD9 | |
| RKSSEASPTAQRSKD | 91 | Q7Z569 | |
| RSHSKDRTLGKPDSL | 1751 | Q9NR48 | |
| DADPGKSSSKRRSSD | 486 | Q9UJX6 | |
| SEGSSVESLKPVRKR | 581 | Q6UB99 | |
| EKLGDTPRKKVRTSS | 501 | Q8WY36 | |
| ARELPSAVSRDKSSK | 521 | O00429 | |
| SRSGLERKPESLSKV | 336 | Q8N9M1 | |
| VSATDLGPERRKSTT | 1601 | Q6V0I7 | |
| GSRKPTASSSRQDKE | 491 | Q96P50 | |
| AATARRKGDSPRSIS | 391 | Q9ULD4 | |
| EASRESSKPRASLKP | 386 | Q66LE6 | |
| SRKDAGKTDSSSLRP | 776 | Q8IY63 | |
| RRPAGGIRESKESSK | 136 | O95567 | |
| SSAPAKTEGRSLESR | 766 | O94989 | |
| GEKSRTVSSRKKPAL | 811 | A6QL64 | |
| SQRRPALKTTGDEKD | 631 | Q8N2N9 | |
| SSTGKESPKVRRHSS | 106 | O94921 | |
| SLKREKTEERLGSPS | 466 | Q9Y4F5 | |
| TRTASEGSEQPKKRA | 391 | Q9UBW5 | |
| ADVRKSKTIPRRGKS | 961 | Q9UKL3 | |
| DGRERSKKSSVSDAP | 1376 | O14646 | |
| GKKSLRSSKSESRSP | 21 | Q96MT7 | |
| SAGNSSLRRTKRKAP | 351 | Q53SF7 | |
| DLSTRSDESPSNKKR | 631 | Q9ULK2 | |
| ISSGRSIRKKRSPLD | 1221 | O43520 | |
| KKGKRRHSSLPTESD | 751 | O14617 | |
| ESLRRKKSDSASSPS | 1186 | P98198 | |
| KKRGRSTDSEVSQSP | 286 | O75175 | |
| GRKASKPISDSREVS | 376 | Q9Y483 | |
| PLRSKRDSLEKESSD | 1086 | Q7Z401 | |
| LTSTSVLKREAPAGR | 151 | Q9Y3T6 | |
| SPVKAKRSRGGEDST | 51 | Q96T37 | |
| LPGILRKDSSGTSKR | 1611 | Q9H0J4 | |
| ARGERKKSVVESSAP | 301 | P48382 | |
| RSEESSKPKGDGSSR | 56 | O95153 | |
| TGVPRRTAKKAESLS | 591 | O95153 | |
| SATGRAKEPLSRATE | 1566 | O95153 | |
| LRQKERKSSAPSASV | 421 | P11161 | |
| TPESATLSEKRRRAK | 606 | Q96TA1 | |
| GITSPSADTNKRKRD | 186 | Q02548 | |
| ISERAKKVRRVPGSS | 311 | O95747 | |
| SSALKDKGSSLEPRQ | 376 | Q99743 | |
| RKSESQRKSTTLSGP | 211 | Q14207 | |
| SRTGTLSRKSIKAPA | 161 | Q9P2A4 | |
| SSPLTSGSKLEREKQ | 46 | Q96LL4 | |
| RTRSPKTKVSLRGET | 6 | E5RJ46 | |
| RKRPGEATAASSEIK | 211 | Q96SQ7 | |
| PKTGLITTTSRKLDR | 1191 | Q14517 | |
| SSKASQDRKLTSTPR | 1576 | Q9Y618 | |
| LRIPSAAGKRKAIST | 226 | Q8NGY5 | |
| ATSKERPRSLVDSKA | 471 | O60320 | |
| FRTKRSASLGPESRK | 121 | A1A4G5 | |
| SKRTQRTGEKAAPRS | 3851 | Q8NEZ4 | |
| KSSESRRNDIKTEPG | 4046 | Q8NEZ4 | |
| GLKESSDKVSRVASP | 2276 | P46821 | |
| SEKGGRAPLSRKSST | 906 | Q66K74 | |
| VTRGRKSRSSVKTPE | 1186 | Q14676 | |
| RGRKNRSSVKTPETV | 1516 | Q14676 | |
| RDSSARLLGKTKDTP | 486 | Q96JG8 | |
| TADSEARSRKTPQKR | 341 | Q9H089 | |
| HRPDLSKTTGKRTSE | 36 | Q9UJA3 | |
| SRRLAKKTAEEPAAS | 336 | Q9NQS7 | |
| KGSRTPSDRTVKKED | 1236 | Q92823 | |
| KKASRTESRESVEGP | 796 | Q6PRD1 | |
| KASLKSPALRRTGST | 786 | Q9ULD2 | |
| TPISKESRTSHKSGR | 496 | Q8IYT1 | |
| KRGSKDNATDSVPLR | 2121 | Q07954 | |
| LGSADKNSRKRAPRS | 706 | P06681 | |
| ERTPSVAGSEKRLRS | 1221 | Q9P266 | |
| SREKKEDSLRGTPAR | 401 | O60318 | |
| TAASRSGLSKAPSRK | 411 | Q6KB66 | |
| VSTRSRSKLPAGKNV | 56 | Q9Y6G9 | |
| SEVSTRARSKLPSGK | 41 | O43237 | |
| PLKGSKTERKTERFS | 2201 | Q5CZC0 | |
| RTLDSGTSEIVKSPR | 186 | Q9H501 | |
| DSFLERPSTSKVRKS | 746 | O14782 | |
| EDTGRSLPSKKERSG | 656 | Q9UKJ3 | |
| RRSLPAEEGSSGKKD | 756 | Q9UKJ3 | |
| PEGTSKKRATRRTSS | 666 | Q96RV3 | |
| RDASKKALGPRRDSD | 106 | P29536 | |
| SVLAKDRGTNPKSAR | 356 | Q08174 | |
| SSKRESKTRLEISNP | 51 | Q92614 | |
| SKLREPTKIGSGRSS | 1176 | Q8IVL0 | |
| ALSSSRPTKKEEDRP | 526 | P53618 | |
| LKSRTGKLRASESPS | 706 | Q6ZNL6 | |
| RRRSLDSIDKGDTPS | 2451 | O94915 | |
| SPDGVKRITATKRET | 11 | Q8TAT6 | |
| ERSRPNSGDEKRKLS | 116 | Q49A26 | |
| SSERGSKSPLKRAQE | 151 | Q49A26 | |
| RRSSIDGSEPAKTSL | 226 | Q6NV75 | |
| TKSDSPRLKSERAEA | 786 | Q6KC79 | |
| RASERASEKGPALKA | 746 | P42356 | |
| REGSRKSSRVKGSAP | 246 | Q8IZD2 | |
| LLEKGTQERSRSPSS | 321 | Q8N4P6 | |
| RQSSLPKDRGKRSSA | 86 | Q9BYS8 | |
| RAENSSKSDLRKSPV | 151 | O00566 | |
| SLPEVRTGKRKRSSS | 286 | Q4G0J3 | |
| SVPRATSSLKARASK | 1411 | Q9ULI4 | |
| ESLALRKRTPSVGKA | 2251 | P46013 | |
| RSRKTKSQPAASTLE | 3201 | P46013 | |
| KEPLSSLARKEGASS | 501 | Q9HAQ2 | |
| SARPASPGSDAEKRK | 71 | O15522 | |
| RKSSSGRRSKEPAEK | 526 | Q9P242 | |
| TGRRKRSAKPETVID | 681 | Q9Y496 | |
| VKEDTTPRSGKDKRR | 221 | Q75WM6 | |
| PRLSRTRDSKGQKSD | 536 | Q8ND30 | |
| SGRKRTPVKDRFSAE | 6 | Q9Y608 | |
| GSPVRKSEEKTDTKR | 1276 | Q7Z6E9 | |
| RRKDSPSRNKDSASG | 1496 | Q7Z6E9 | |
| TGDSKKSNSSPSRDR | 1526 | Q7Z6E9 | |
| PSKKLRSGSSFSQRA | 406 | A2A3N6 | |
| RDSLKKRPVSDLLSG | 811 | Q16825 | |
| SLRKAEKRGAKTPST | 136 | Q8WX93 | |
| TEKSLKSPSDTLDGR | 351 | Q86YC2 | |
| KRKRTADKSTSTSDP | 896 | Q6PIJ6 | |
| EKTRAKGPSESSKER | 171 | Q8TEA8 | |
| RSTVSKSKDPSGLLI | 11 | Q96A65 | |
| AAKKRERATSDPRTT | 776 | Q01780 | |
| ELSGRKRASSLQTSP | 811 | Q8NHM5 | |
| RPIKSVSERLSSAKT | 591 | P54132 | |
| STSEEKASRREPLKA | 916 | Q6AI39 | |
| TFKASKRAEVTRGPS | 1466 | Q4AC94 | |
| AETRKFTRALSKPGT | 11 | Q9BZ29 | |
| ASKSTPDGTIKDRRL | 2306 | P51587 | |
| VKLRTSRISSKARDP | 371 | Q6UXV0 | |
| RADSDKRTPKTSRAS | 231 | Q8NEG2 | |
| KTERRARSSPKSNDS | 246 | Q53EP0 | |
| ARSKKRALSLSPLSD | 141 | Q8NEA6 | |
| KRGEDLSKSRRSRSP | 846 | Q9HC77 | |
| ESSGTKRDEKTPRAG | 41 | Q96RY5 | |
| RAKDKGRPVSLSSVS | 1011 | Q8TDW7 | |
| SGRRKREDLTSTLPS | 71 | Q6PIV2 | |
| STASSPRGAKKSRLR | 396 | Q3T8J9 | |
| KGPSKLNDRADSRRS | 71 | P01730 | |
| SSESPGRDKGKLSRL | 881 | P00519 | |
| PSSELQGSDKRSREK | 2491 | Q12955 | |
| QGSDKRSREKIATAP | 2496 | Q12955 | |
| LDDSDLPKTSSGRRR | 1286 | Q9NSI6 | |
| ISSTLPSKESRRKGG | 246 | Q86V48 | |
| CRVIKSSGREKPDSD | 646 | Q86V48 | |
| TSRSTSGEPKERDKE | 676 | Q9P0L2 | |
| RESGRKASSTAKVPA | 441 | Q7KZI7 | |
| DQRISPKDKSTAGRE | 1196 | Q8TEP8 | |
| ASSERKRARIPSGKA | 6 | Q9NTM9 | |
| EKKTRTDSTSDGRPA | 4361 | Q14204 | |
| TGSRKRKAPAVEADA | 6 | Q5VU92 | |
| KKPLAVTGSDDRSVR | 336 | Q6ZMW3 | |
| RKKQELSNPSSGSRT | 826 | P57679 | |
| ASSPTKRKGRSRALE | 101 | Q9Y4K1 | |
| RSRSSSPGNKSKKTE | 101 | Q7L014 | |
| SRREDPISAGSRKTS | 461 | Q7Z2K8 | |
| RSKDPGSAERTAQKR | 6 | Q9ULU4 | |
| SPSPRRETGKESRKS | 816 | Q99590 | |
| DTDDDLPKSRASKRT | 1026 | Q8NG08 | |
| RTERSKGARKTSVSP | 236 | O75807 | |
| DAREKISLKRSSPAA | 116 | Q9BY77 | |
| STVTRKSDKTGRPLE | 176 | Q3MIW9 | |
| KALSKASPNTRSGTR | 2071 | Q14980 | |
| SRKEKGGRSPDEVTL | 311 | Q9UKS6 | |
| DGKLRGRSKRSSDPS | 246 | O00167 | |
| TVKSESPGVRRKRVS | 261 | Q13233 | |
| SDRVSASKRRSSPSK | 21 | P61328 | |
| ASKRRSSPSKDGRSL | 26 | P61328 | |
| TIRREAGSCSKSSPK | 821 | Q5JY77 | |
| GAAKEEPKRRSARLS | 11 | P05114 | |
| SRSGSSPEVKDKPRA | 1596 | Q9UQ35 | |
| AKTSRTPSRDSQKLT | 171 | A4FU49 | |
| GDGKRKRSSSSPRSI | 196 | Q7Z6J9 | |
| ASRRELELPSSKTEG | 566 | O95425 | |
| KRSLSLGDKEISRSS | 1071 | Q9UMZ2 | |
| LLDPAEGLSRRKKTS | 11 | Q8WV15 | |
| KAGERDKAPSLKSRS | 96 | Q7L2K0 | |
| RKATDRGVAPDSKTT | 996 | Q6ZUX3 | |
| TATAAKPKRKRTGSD | 276 | Q15270 | |
| RTGSDSKSGKPRRAR | 286 | Q15270 | |
| SAKTRRVTQRKPSSG | 16 | Q9BWX1 | |
| STPSSRVKGREASGK | 21 | A5D8V7 | |
| GSEPSKKRKRRTSFT | 601 | P78424 | |
| TVARGKATEAPKRSA | 141 | Q9H6K5 | |
| SGSRPLADRGKKTEE | 31 | Q96I23 | |
| KASQVKRSPSDAGRS | 1106 | Q8IVL1 | |
| PKSSALVSRSAGRKS | 1176 | Q8IVL1 | |
| ALPGSSKRRRKEETT | 236 | Q96QT6 | |
| LDESSLTASPQKKRR | 926 | Q9NZC9 | |
| PTRKRSLSSDKRLAA | 1026 | Q96PQ0 | |
| RKRKRDSDAGSSTPT | 1411 | P51532 | |
| PLKRRSKSETGDSSI | 281 | O43166 | |
| ERDESSGPKTLKSLT | 871 | Q92835 | |
| TVDSSIFRKLRSSKP | 296 | O60292 | |
| LSASSRARPKAKDED | 601 | Q9Y6H5 | |
| GPDTKRAKLDSSETT | 191 | Q9UBE0 | |
| LLKFRTDKGRDPSSD | 246 | Q9UBE0 | |
| KKPRGTESLSASESL | 2756 | O75592 | |
| VSTDTSSLRRADPKG | 31 | A6NGB9 | |
| RVKGEAPAKSSTLRD | 11 | Q9NTN3 | |
| GSERKRKRTSIAAPE | 271 | Q15319 | |
| GNAKSSRIKRSAPLS | 896 | Q4LDE5 | |
| ASKGRRTVDSTPLSV | 976 | Q5VT25 | |
| SSLERGRKVSIVSKP | 1141 | Q9NRY4 | |
| SSDSPKELKRRNSSS | 856 | Q96QB1 | |
| KETLSRRGPSASSVA | 101 | Q9NZQ3 | |
| PEKSQKRGSSSRSKS | 236 | Q13243 | |
| KRGSSSRSKSPASVD | 241 | Q13243 | |
| DQKPGPSERSRATKS | 541 | Q15424 | |
| RDVSKKAKRSPSGSR | 976 | O15042 | |
| SAARDKASRLGPLTT | 196 | Q9BWW9 | |
| KARLVKPSSSSSGSR | 281 | Q9H6B4 | |
| RDSSSEKDGRSPNKR | 181 | Q96RK0 | |
| RTPSSAKEKIEGRSQ | 1436 | P42695 | |
| KVARSAKGREASLSP | 346 | Q8IYJ2 | |
| SGQKRKRSPEGERTS | 926 | Q9NRU3 | |
| PTEKTTGARRSKAKS | 156 | Q5QJE6 | |
| TGARRSKAKSLTDPS | 161 | Q5QJE6 | |
| TPEKKQSESSRGRKR | 111 | Q9UKI8 | |
| KIIRRRSSTSLPGDK | 446 | Q8IXZ2 | |
| SSEKLKERPSSREDT | 431 | Q9UDY2 | |
| EDRGRTLRSSKPKDF | 621 | Q7Z2Z1 | |
| SRGTKTDSKIEGPER | 1276 | Q9C0A1 | |
| SSSAASSPERKKRIL | 1451 | Q8WWQ0 | |
| SSKERDHRGSSSPRK | 371 | B3KS81 | |
| REAPGTSSSRKSLKT | 136 | Q8IWN7 | |
| QDKEARTKESRSSPA | 676 | O94956 | |
| RKKEKDTDSTGSPDR | 16 | Q9BQI5 | |
| ERRSSAAGKSEPLEK | 46 | Q9Y458 | |
| LSKTSGDLKPRSASD | 711 | Q5TCZ1 | |
| RREKRSLSDKEPSSG | 136 | O95155 | |
| SPQIRKTATAGRSKS | 916 | O75044 | |
| SSTGDLPKAKTRAAD | 496 | P78362 | |
| KRKTDRGTDDSPKDS | 111 | Q6IPX3 | |
| LRKASLRSSSSLGPK | 186 | Q658T7 | |
| SSDSGSAEKRRRKSP | 176 | Q9NS37 | |
| SSKGSTGPRKTEVLR | 1336 | Q9HCK4 | |
| SSQFEKTRKVSGPRS | 456 | Q9NW08 | |
| KPTSVSGRHSKARDS | 541 | Q9Y2I9 | |
| KRSRVTTSLEALPTG | 141 | Q8IV63 | |
| ITSEEERSPAKRGRK | 1671 | Q12888 | |
| ERSPAKRGRKSATVK | 1676 | Q12888 | |
| ASASAPPAAKRRKTD | 61 | A6NLC8 | |
| SKSRLRFSSSKISPA | 721 | Q92543 | |
| KGSRKKRSLPREESA | 951 | Q00722 | |
| KRKTDRGTDDSPKDS | 111 | Q969E4 | |
| PEKVNSRDTAGRKST | 46 | Q9H2K2 | |
| SSAKLSRGDSLKEPT | 371 | Q9C0B5 | |
| DPSKDRAAKRLSLES | 21 | O94811 | |
| KRAKRLSSAPSSRAE | 116 | Q9UDW3 | |
| SARRDAKKLVRSPSG | 6 | Q9BQ24 | |
| SLAEKRSLREKSRTP | 171 | Q7Z403 | |
| TASKVNTSKPRGRIA | 571 | Q8ND82 | |
| VSLKPSRSRSKADSS | 1066 | Q70CQ4 | |
| ADSTSDVKRGAPKRQ | 476 | Q9C0D7 | |
| SPSVRSSKDGKLLAA | 36 | Q9Y275 | |
| KRPSSLHKRSGTDTS | 1386 | A3KMH1 | |
| TGAEERSAKPTKLAS | 166 | Q14669 | |
| SPRRSSREKEQSKTG | 241 | Q14669 | |
| NSRSERRPSGDKKTS | 336 | Q7L8A9 | |
| RRGKNFSSTSDLSKP | 106 | Q9NQZ8 | |
| VSPRKRGLSSSEKDN | 81 | Q8IYH5 | |
| SGSSPKRRRAEDKDE | 121 | Q01664 | |
| LVGGKRRSRSKSSDP | 491 | O60293 | |
| GKKPSLRSSADRRSS | 621 | Q5VUA4 | |
| SPGLARKRSLSESSV | 851 | Q9H2Y7 | |
| SERGRSPKRLTDLDK | 2041 | P18583 | |
| KDRSLSGSLRKNSSP | 1151 | Q70EL1 | |
| SPKSEAPRTTRDEKR | 186 | P22415 | |
| SLRDSVKGPVESKRA | 1226 | Q9P2D8 | |
| VKPTGLRKRTSSIAD | 1641 | Q9Y4I1 | |
| SSLLKKRDSFRTPRD | 296 | Q14896 |